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There is variability in the pattern of weight change in response to a weight loss 
intervention (i.e., slowing of subsequent weight loss, cessation of weight loss, weight 
regain).  A reduction in resting energy expenditure (REE) may partially explain the 
observed variability.  Few studies have examined the effect of initial weight loss on 
change in REE.  PURPOSE: To examine the change in REE in response to weight loss 
across a 4-week period in overweight and obese males and females.  METHODS:  
Thirty-seven subjects (body mass index 25.0-39.9 kg/m2; males = 14, females = 23) 
participated in a 4-week intervention with random assignment to an Experimental Group 
or a no treatment Control Group.  The experimental group was instructed to reduce 
energy intake to 1200-1500 kcal/d and participate in 100 min/wk of moderate aerobic 
exercise.  The control group was instructed to maintain current eating and exercise 
behaviors.  Assessments of body weight, body composition, and REE were conducted at 
0 and 4 weeks.  REE was expressed as absolute REE (kcal/d), REE relative to body 
weight, (kcal/kg/d), REE relative to lean body mass (kcal/kgLBM/d).  RESULTS: 
Thirty-five subjects completed the study (94.6%).  There were significant differences 
(p<0.05) for change in outcomes between the experimental and control groups for body 
weight (-3.3+1.7 vs. 0.6+1.1 kg) lean body mass (-0.6+0.9 vs. 0.2+0.9 kg), absolute REE 
(-205.8+193.0 vs. -11.4+ 140.6 kcal/d), and REE relative to lean body mass (-3.3+2.9 vs. 
-0.4+2.6 kcal/kgLBM/d).  There was a trend toward a significant difference between the 
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groups (p = .07) for REE relative to body weight (-1.4+1.9 vs. -0.3+1.5 kcal/kg/d).  When 
the groups were combined, there was a correlation between change in REE and change in 
body weight was r=0.41 (p<.05), and change in REE and change in lean body mass was 
r=0.44 (p<.01).  CONCLUSIONS:  Results indicate that absolute and relative REE are 
significantly reduced in response to weight loss over a 4-week period.  The modest 
correlations between change in REE and both body weight and lean body mass may 
suggest that additional physiological mechanisms influence REE during the acute phase 
of weight loss. 
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CHAPTER I 
INTRODUCTION AND RATIONALE 
 
1.1  Introduction 
The percentage of adults in the U.S. population that are overweight and obese 
continues to rise.  Based on the National Health and Nutrition Examination Survey 
(NHANES) conducted between 1999 and 2000, approximately 34% of American adults 
are classified as overweight, defined as a body mass index (BMI) of 25.0 to 29.9 kg/m2, 
and approximately 30% are classified as obese (BMI > 30 kg/m2) totaling 64% of 
American adults who are either overweight or obese (21,22).  As illustrated in Figure 1.1, 
although the prevalence rates of overweight adults has not increased significantly, the 
prevalence of obesity has doubled when comparing national surveys conducted over the 
past 20 to 30 years (21, 22).    
Figure 1.1  Rates of overweight and obesity as a percentage of the US population 
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The rising prevalence of US adults who are either overweight or obese is a 
concern because of the association with increasing rates of chronic health conditions 
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including heart disease, diabetes, cancer, and associated risk factors such as, 
hypertension, hyperlipedemia, and hyperinsulimea (13, 37).  Several studies, however, 
have indicated that many of these health risks associated with overweight and obesity can 
be reduced with weight loss (4, 27, 43, 57).  This may be a result of significant 
improvements in coronary heart disease (CHD) risk factors and type II diabetes observed 
with even modest weight reduction (i.e., 10% of initial body weight) (4, 43, 57). 
Examination of weight loss interventions appears to demonstrate that the pattern 
of weight loss varies across the intervention period (24, 28, 51, 52).  For example, 
Wadden et al. (51) reported from a 52 week intervention utilizing diet and aerobic 
exercise, attenuation in weight loss resulting from a 1200 kcal/d diet with mean weight 
loss varying from 1.45 kg/week in the initial week of treatment to 0.10 kg/week in the 
final weeks of treatment.  This slowing of weight loss is consistent with a prior study by 
Wadden et al. also utilizing diet and aerobic exercise, reporting mean weight loss of 0.82 
kg/week for weeks 0-5, 0.73 kg/week for weeks 6-9, 0.43 kg/week for weeks 10-13, 0.58 
kg/week for weeks 14-17, 0.40 kg/week for weeks 18-21, 0.43 kg/week for weeks 21-25, 
and 0.17 kg/week for weeks 25-48 in the group prescribed 1200 kcal/d (52).  
Moreover, significant weight regain of approximately 46%, 61%, and 71% of 
weight lost have been reported within 1, 2, and 3 years respectively following initial 
weight loss (1, 5, 6, 49, 51).  Therefore, it is important to understand the factors that 
contribute to these patterns of weight loss and regain. 
There may be physiological mechanisms that contribute to changes in pattern of 
weight loss in response to an intervention.  One potential physiological factor may be 
resting energy expenditure (REE), which is the largest determinant of daily energy 
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expenditure (15).  It has been demonstrated that a reduction in REE corresponds to a 
slowing of subsequent weight loss and an increase in the rate of weight regain (24, 28, 
52).  Therefore, changes in REE during the weight loss process may partially explain the 
observed pattern of weight change in response to treatment.  However, under-reporting or 
poor compliance to dietary or exercise interventions may also be a contributing factor to 
the slowing of weight loss. 
1.2 Rationale 
While a failure to comply with behavioral changes to diet and/or exercise may be 
partially responsible for difficulty in weight control, there may be physiological processes 
that can also contribute to observed patterns of weight change.  One potential factor 
which may influence changes in body weight, and the focus of this study, is a reduction 
in resting energy expenditure (REE) that may correspond to energy restriction (16, 24).  It 
appears that REE decreases significantly with energy restriction with and without the 
inclusion of aerobic exercise within the initial 3-5 weeks of treatment (28, 30, 52, 53).  
Further, the observed reduction in REE appears to occur regardless of whether REE is 
expressed in absolute (kcal/d) or relative terms based on total body weight (kcal/kg/d) or 
lean body mass (kcal/kg LBM/d) (16, 29, 52, 53). 
1.3 Statement of the problem 
 The purpose of this study was to examine the change in resting energy 
expenditure (REE) while consuming a reduced calorie diet combined with aerobic 
exercise across a 4-week period in overweight and obese males and females compared 
with a no treatment control.  
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1.31 Sub-problems 
1. To examine the change of absolute change in REE (kcal/d) in the experimental 
condition compared to the control condition. 
2.  To examine the relative changes in REE based on total body weight 
(kcal/kg/d) and lean body mass (kcal/kg LBM/d) in the experimental condition 
compared to the control condition. 
3.  To examine the change in total body weight (kg) in the experimental condition 
compared to the control condition. 
4. To examine the change in lean body mass (kg) in the experimental condition 
compared to the control condition. 
1.4 Hypothesis 
It was hypothesized that overweight and obese males and females in the experimental 
condition would show a significant reduction in resting energy expenditure as a result of 
consuming a 1200-1500 kcal/d diet combined with aerobic exercise for a 4-week period 
when compared to the control condition. 
 1.41 Sub-hypotheses 
It was hypothesized that as a result of the four-week intervention: 
1. REE relative to changes in total body weight (REE/kg) would be significantly 
reduced in the experimental condition compared to the control condition. 
2. REE relative to changes in lean body mass (REE/kgLBM) would be 
significantly reduced in the experimental condition compared to the control 
condition. 
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3. Total body weight would be significantly reduced in the experimental condition 
compared to the control condition. 
4. Lean Body Mass (LBM) would not be significantly reduced in the experimental 
condition compared to the control condition. 
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CHAPTER II 
REVIEW OF RELATED LITERATURE 
 
2.1 Introduction 
This study examined the time-course of change in resting energy expenditure 
(REE) in overweight and obese males and females over a 4-week period.  Subjects were 
randomly assigned to an experimental condition (prescribed a reduced calorie diet + 
aerobic exercise) or a control condition (no intervention).  Additional measures included 
body weight and body composition.  REE is expressed as an absolute value (kcal/d), 
relative to body weight (kcal/kg/d), and relative to lean body mass (kcal/kg LBM/d).  The 
following literature review was conducted to justify the need for this study.  
2.2 Obesity:  Public health concern 
 Obesity and overweight is an increasing public health problem in the United 
States.  As illustrated in Chapter I, Figure 1.1, the prevalence rates overweight and obese 
adults total 64% when combined.  Based on the National Health and Nutrition 
Examination Survey (NHANES), the prevalence of overweight, defined as a body mass 
index (BMI) of 25.0 to 29.9 kg/m2 increased from the 1976-1980 survey (31.5%) to the 
1999-2000 survey (34%) (21, 22).  Moreover, the prevalence of obesity (BMI > 30 
kg/m2) has doubled (from 15% to 31%) during this same period of time (21, 22).   
The increasing prevalence of overweight and obesity is of concern because of the 
corresponding increase in health-related outcomes observed with an increase in body 
weight.  For example, research has shown that obesity is associated with chronic health 
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conditions such as heart disease, diabetes, cancer, hypertension, dyslipidemia, and 
hyperinsulimea (13, 26, 37, 44).   
It appears that mortality increases with a corresponding increase in BMI.  A 
prospective study (37) examined the association between BMI and both overall morbidity 
and mortality in 115,195 U.S. women, and showed that the relative risk of death from all 
causes was lowest in women with BMI values < 19 kg/m .  Moreover, there was a 60% 
greater relative risk in women with BMI values > 27 kg/m  compared to women with 
BMI < 19 kg/m  with the risk more than doubling in women with BMI 
2
2
2 > 29 kg/m .  Data 
from 5 prospective cohort studies and 1991 national statistics on body mass index 
distributions, population size, and overall deaths was used to estimate the number of 
deaths annually that are attributable to obesity in both men and women in the United 
States.  The mean estimate of deaths attributable to obesity in the United States was 
280,184.  Moreover, 80% of the estimated obesity-attributable deaths occurred among 
individuals with a body mass index (BMI) greater than 30 kg/m  (2).
2
2
2.3 Effect of weight reduction on morbidity and mortality 
Several studies have indicated that weight loss reduces health risks associated with 
overweight and obesity (4, 27, 43, 57), with significant improvements in CHD risk 
factors that can be observed with even modest weight reduction, (i.e., 10 % of initial 
body weight) (4, 57).  A review by Anderson et al. (4) concluded that for each kilogram 
(kg) of weight lost, there is a decrease in fasting serum cholesterol  (1.0%), low-density 
lipoprotein cholesterol (0.7%), triglycerides (1.9%), systolic blood pressure (0.5%), 
diastolic blood pressure (0.4%), and blood glucose (0.2%), with an increase in high-
density lipoprotein cholesterol (2.0%).   
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 The risk for development of type II diabetes mellitus appears to be reduced with 
weight loss as well.  In a prospective study by Resnick et al. (43), overweight men and 
women were followed for 10 years to determine the effects of weight gain and weight 
loss and their association with the risk of type II diabetes.  The results showed that, 
compared to overweight men and women who remained weight stable, each kg of weight 
gained was associated with a 49% increase in risk of developing diabetes in the following 
10 years, with each kg of weight lost being associated with a 33% lower risk of diabetes 
in the following 10 years.   
Research has also demonstrated that mortality in overweight adults with obesity 
related co-morbidities is reduced with weight loss of approximately 10% of initial body 
weight (57).  It has also been shown that a weight loss of 20-29 lb is associated with a 
25% reduction in total mortality (RR = 0.75; 95% CI 0.67-0.84), and a 28% reduction in 
CVD and diabetes mortality (RR = 0.72; 0.63-0.82) in overweight individuals with 
diabetes who reported intentional weight loss compared to overweight individuals with 
diabetes who did not report intentional weight loss (56).  Because of the increased risk of 
mortality and morbidity due to overweight and obesity, and the improvement in mortality 
and morbidity resulting from weight loss, it is important to better understand the 
mechanisms that may affect success of weight loss and weight control in U.S. adults. 
2.4 Patterns in weight loss across intervention periods 
It appears that the pattern of weight loss varies across intervention periods 
primarily connected to differences in the rate of weight loss between treatment groups 
and/or changes in the pattern of weight loss within the same treatment group over time.  
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Examples of variation in patterns of weight loss include slowing in rate of weight loss, 
cessation of weight loss, and even weight regain (24, 28, 51, 52).   
The mean rate of weight loss between time points within treatment groups appears 
to slow over time (28, 51, 52).  Wadden et al. (51) studied 21 overweight females who 
were randomized to a balanced deficit diet, which is a reduced calorie diet balanced to 
meet guidelines for macronutrient composition, and instructed to consume 1200kcal/d for 
52 weeks compared to a very low calorie diet (VLCD) group.  Aerobic exercise was also 
introduced in both groups at week 8.  The mean loss of weight in the 1200 kcal/d group 
during the first week of treatment was 1.45 kg/week. From weeks 2-5 the mean weight 
loss was 0.65 kg/week compared to 0.32 kg/week from weeks 13-17, and 0.29 kg/week 
during weeks 17-26.  The mean weight loss for weeks 26-52 was 0.10 kg/week.  These 
findings are consistent with a previous study by Wadden et al. (52) that also demonstrates 
this attenuation in weight loss over time in a similar study comparing a balanced deficit 
diet group (BDD) to a VLCD group and the inclusion of aerobic exercise at week 8 in 
both groups.  The mean weight reduction per week for the balanced deficit diet (BDD) 
group was 0.82 kg/week in weeks 0-5,  0.73 kg/week in weeks 6-9, 0.43 kg/week in 
weeks 10-13, 0.58 kg/week in weeks 14-17, 0.40 kg/week in weeks 18-21,  0.43 kg/week 
in weeks 21-25, and 0.17 kg/week in weeks 25-48.   
There are a number of factors that may influence this variability in patterns of 
weight loss in response to intervention programs.  One potential contributing behavioral 
factor is caloric intake.  The study by Wadden et al. (52) demonstrated differences in 
weight loss across 48 weeks between consuming 1200kcal/d versus a very low calorie 
diet (VLCD) consisting of 420 kcal/d for 16 weeks followed by re-alimentation to 1200-
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1500 kcal/d for weeks 24-48.  Aerobic exercise was introduced in both groups at week 8.  
The VLCD group lost approximately 26.0kg versus 12.6kg in the 1200 kcal/d group 
through the initial 21 weeks of treatment.  However, some of the weight lost was 
regained in the VLCD group during weeks 22-48 (consuming 1200-1500 kcal/d) while 
the 1200 kcal/d group continued to lose weight, resulting in total weight losses of  21.6kg 
in the VLCD group compared to 18.2kg in the 1200 kcal/d group.  These data suggest 
that a lower caloric intake elicits greater reductions in weight in the short-term, but may 
not allow subjects to maintain weight losses once re-alimented to a balanced deficit diet. 
The inclusion of exercise is another behavioral factor that may contribute to 
differences between groups in response to weight loss treatment.  The inclusion of 
exercise has been shown to increase the amount of weight lost in some studies (29, 33).  
In a study by Jakicic et al. (32) that combined aerobic exercise with caloric restriction for 
weight loss, analysis of data demonstrated a dose response relationship with exercise and 
weight lost.  When grouped by total minutes of exercise per week, subjects who exercised 
> 200 minutes per week lost significantly more weight (~13.1 kg) compared to subjects 
who exercised 150-200 minutes per week (~8.5 kg) and subjects who exercised < 150 
minutes per week (~3.5 kg).  Increased weight loss resulting from the addition of exercise 
is most likely due to an increase in energy expenditure compared to non-exercisers.   
A physiological factor that may impact differences in response to weight loss 
treatment is resting energy expenditure.  Resting energy expenditure has been shown to 
impact the response to weight loss treatment in several studies (24, 28, 52), with a 
reduction in REE that corresponds to slowing of subsequent weight loss (28, 52).  It 
appears that the rate at which subjects reduce body weight is decreased as REE decreases 
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from baseline values (52).  The study by Wadden et al. (52) in 1994 which compared a 
BDD group utilizing 1200 kcal/d to a VLCD group demonstrated the following mean 
reduction in body weight in the BDD group per week: weeks 0-5 (0.82 kg/week), weeks 
6-9 (0.73 kg/week), weeks 10-13 (0.43 kg/week), weeks 14-17 (0.58), weeks 18-21 (0.40 
kg/week), weeks 21-25 (0.43 kg/week), and weeks 25-48 (0.17 kg/week).   REE 
measures taken at the same time points represent a corresponding reduction in REE from 
baseline values:  weeks 0-5 (193 kcal/d), weeks 6-9 (214 kcal/d), weeks 10-13 (266 
kcal/d), weeks 14-17 (251 kcal/d), weeks 18-21 (224 kcal/d), weeks 22-25 (188 kcal/d), 
and weeks 25-48 (203 kcal/d) (52).   
A study by Henson et al. (28) demonstrated attenuation in the rate of weight lost 
in 14 moderately obese women consuming an 800kcal/d diet for 9 weeks that was not 
impacted by the inclusion of aerobic exercise from weeks 3-6.  REE was measured at 
baseline and at the end of weeks 3, 6, and 9.  REE was decreased by 13% at week 3, 12% 
at week 6, and 17% at week 9.  A progressive slowing in the rate of weight lost was 
evident over the three-week increments with a 4.1 kg loss by week 3, 3.0 kg loss from 
weeks 4-6, and 2.4 kg loss from weeks 7-9.  These results suggest a potential link 
between reduction in REE with a corresponding slowing of weight loss.   
While there are a number of factors, both behavioral and physiological, that may 
be partially responsible for inconsistencies in response to weight loss treatments, for the 
purpose of choosing one focal point, resting energy expenditure will be the focus of this 
study.  
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2.5 Factors influencing resting energy expenditure 
 
 Several studies show that energy restriction during weight loss treatment 
corresponds to decreases in REE with both short-term and long-term interventions (7, 16, 
28, 34, 52).  A meta-analysis conducted by Ballor et al. (7) based on 60 different group 
means from 33 studies averaging 12 weeks in length indicated that collectively, dietary 
restriction resulted in an absolute reduction in REE of approximately 12%.  When 
adjusted for reduction in body weight, the relative reduction in REE (kcal/kg/d) was less 
than 2%.  
Although reductions in REE have been attributed to other factors such as loss of 
lean body mass (LBM), loss of total body weight (TBW), and genetic differences (12, 29, 
52, 53), other studies have demonstrated significant reductions in REE independent of 
changes in TBW and/or LBM (16, 18, 30, 34, 52).  In a study by Leibel et al. (34), obese 
women were reduced to 10% below initial body weight through caloric restriction.  This 
10% weight loss after approximately 6-14 weeks of treatment corresponded to a 
reduction in REE of 4 kcal/kgLBM/d (~240 kcal/d reduction independent of changes in 
LBM). 
A number of weight loss studies that have examined changes in REE with caloric 
restriction and weight loss have demonstrated that there is a significant reduction in REE 
when expressed relative to LBM (kcal/kgLBM/day) within 10 days to 5 weeks of 
initiating treatment (30, 52, 53).  These same studies have reported that there is no 
significant reduction in REE relative to changes in LBM (kcal/kgLBM/day) post-
treatment (12-48 weeks).  This suggests that the initial reduction in REE in these studies 
was not due to changes in LBM.  Wadden, et al. (52) instructed 9 obese females to 
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consume a 1200 kcal/d balanced deficit diet for 48 weeks with aerobic exercise 
introduced at week 8.  Results showed that there was a significant decrease in mean REE 
adjusted for changes in lean body mass (9.1 + 4.1%) within 5 weeks of initiation of 
treatment.  Adjusted REE measured after 48 weeks of treatment was no longer significant 
due to LBM lost over time.  These data suggest that the initial reduction in REE may 
have been a result of caloric restriction and not a lowered LBM.  In this same study, the 
reduction in REE apparent early in the weight loss process corresponds with a slowing of 
the rate of weight lost (as discussed in section 2.4).   
Although several studies have examined the relationship between caloric 
restriction and reduction in REE, a limited number of these studies have examined 
changes in REE in the acute phases of treatment during a reduced calorie diet utilizing 
1200-1500  kcal/d diet.    Hill et al. (30) and Weinsier et al. (53) measured changes in 
REE within the first 10-21 days of initiating treatment and showed reduction in REE of 
13% and 6% respectively.  However, a limitation to these studies is that both studies 
prescribed patients to adhere to an 800kcal/d diet.   
In addition, it is not clear as to whether a decrease in LBM triggers a decrease in 
REE in the acute phase of weight loss or if a decrease in REE may be directly linked to 
reduced caloric intake.  By including measurement of changes in REE relative to LBM, 
this study may provide information to help better understand the link between change in 
REE and change in LBM.  If it is found that initial change in REE occurs independent of 
change in LBM, future studies may examine change in REE in comparison to change in 
LBM as a result of caloric restriction and weight loss over a longer period of time to 
determine the relationship between these two factors.  
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If reduction in REE can be detected and adjusted for early in the weight loss 
process, manipulation of factors that contribute to a reduced REE may counter 
attenuation of rate of weight loss corresponding to a reduction in REE.  If it is found that 
caloric deficit is an independent factor impacting REE, the level of caloric deficit could 
potentially be adjusted to minimize reduction in REE.  The implication of these findings 
may contribute to the development of treatment programs that improve success rates in 
weight loss.    
2.6  Summary 
The prevalence of overweight and obesity continues to increase and is at epidemic 
proportions in the United States (21, 22).  It has been demonstrated that overweight and 
obesity increase the risk of morbidity and mortality in adults when compared to those of 
normal weight, primarily from cardiovascular disease through co-morbidities associated 
with being overweight and obese such as hypertension, diabetes, and atherosclerosis (13, 
37).  It has also been shown that even modest reductions in weight can decrease the risk 
of morbidity and mortality in overweight and obese adults (4, 57).   
Current strategies for weight loss appear to show variability in the pattern of 
weight loss during weight loss treatment programs (24, 28, 51).  Therefore, it is important 
to gain a better understanding of physiological factors that influence energy balance and 
weight loss.  As mentioned, REE appears to decrease with caloric restriction and weight 
loss and therefore may be an important physiological parameter to examine.  Because 
studies examining the reduction in REE in the initial phase of weight loss treatment 
programs (weeks 1-4) are limited, this study will contribute to the literature regarding this 
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process.  Therefore, the focus of this study was to examine the change in absolute and 
relative changes in REE over a 4-week period. 
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CHAPTER III 
METHODOLOGY 
 
3.1  Subjects 
 Thirty-seven overweight (BMI = 25.0 to 29.9 kg/m2) or obese (BMI = 30.0 to 
39.9 kg/m2) males and females participated in this study.  Subjects were randomly 
assigned to either an experimental condition (reduced calorie diet) or a control condition 
(no intervention).  Subjects were excluded based on the following criteria: 
1. Post-menopausal (self-reported) 
2. Diagnosis of cardiovascular disease: 
 a. Previous occurrence of a myocardial infarction 
b. Previous occurrence of stroke 
 c. Presence of an uncontrolled cardiac arrhythmia 
3. Diagnosis of metabolic diseases: 
 a. Hypothyroidism or hyperthyroidism 
 b. Type I or type II diabetes 
 c. Other metabolic diseases that may affect metabolism 
4. Uncontrolled hypertension (systolic blood pressure > 140 mmHg and/or  
    diastolic blood pressure > 90 mmHg or currently taking medication to control  
    blood pressure) 
 
 
 
 16
5. Currently taking medications that affect heart rate: 
 a. Beta Blockers 
 b. Calcium Channel Blockers 
 c. Other medications known to affect heart rate 
6. Currently taking medications that affect metabolic rate or dietary intake: 
 a. Appetite suppressants  
 b. Fat-loss supplements 
c. Thyroid medications (i.e., Synthroid) 
d. Psychotropic medications that affect appetite or metabolic rate 
7. Participation in a research project involving weight loss or physical activity 
within the previous 12 months 
8. Loss of > 10% of their body weight within the previous 12 months 
9. Participation in any other research study that may impact the outcome of this 
study 
10.  Currently pregnant (self reported), pregnant in the previous 6 months or 
planning on becoming pregnant in the next 6 months 
11.  Currently being treated for cancer   
12.  Report being treated for any cardiovascular, orthopedic, psychological, 
neurological, or metabolic disorder or any other medical condition that could 
impact body weight, diet, or physical activity. 
13.  Physical activity > 3 days per week for > 20 minutes per day over the 
previous 6 months 
14.  Cigarette smoking 
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15.  Inability to attend weekly sessions or possibility of relocating out of the 
Pittsburgh area during the study period 
 
Subjects were recruited with fliers and other media campaigns (see Appendix H 
for example).  Males and females who expressed interest were provided a telephone 
number to call to be screened by research staff to determine initial eligibility (Appendix 
I).  Those who were eligible to participate were invited to attend an orientation session at 
which time the study was described in greater detail.  At the conclusion of the orientation 
session, interested participants signed an informed consent (Appendix A) at which time 
all questions regarding risks and benefits as well as purpose and procedures of this study 
were addressed.  Volunteers completed a physical activity readiness questionnaire (PAR-
Q) (Appendix B) and general health history questionnaire (Appendix C) prior to 
participation in this study, and information obtained from these questionnaires was used 
to determine participant eligibility.  The PAR-Q and the general health history 
questionnaire were evaluated by a member of the research staff.  If a volunteer answered 
yes to any of the exclusion criteria on the general health history questionnaire, he or she 
was excluded from participating in this study.  If a volunteer answered yes to any of the 
questions on the PAR-Q, he or she was required to provide a physician’s consent 
(Appendix D) in order to participate in this study.  The University of Pittsburgh 
Institutional Review Board approved all experimental procedures.     
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3.2  Experimental design 
This study was a randomized controlled experimental design.  Subjects were 
randomly assigned to either an experimental condition (reduced calorie diet of 1200-1500 
kcal/d + 100 minutes per week of aerobic exercise) or a control condition (no 
intervention) for a period of 4 weeks.  The following outcome measures were assessed: 
height, weight, resting energy expenditure (REE), and body composition via bioelectrical 
impedance analysis (BIA) at 0 and 4 weeks in all subjects.   In addition, physical activity 
and dietary intake were assessed as process measures.   
Figure 3.1 Time-course of experimental design 
Experimental 
Group 
Reduced energy intake (1200-1500  kcal/d) 
100 minutes of moderate physical activity per week    
Control  
Group 
No change in energy intake  
No change in energy expenditure from physical activity     
 ? ? ? ? ? 
 Week 0 
Assessment 
Week 1  
Weight Only in 
Experimental 
Group 
Week 2  
Weight Only in 
Experimental 
Group 
Week 3  
Weight Only in 
Experimental 
Group 
Week 4 
Assessment 
 
 
3.3 Assessments 
 Assessments were conducted at weeks 0 and 4.  Assessments consisted of the 
following measures: 
1. Height and weight 
2. Resting Energy Expenditure (REE) 
3. Body Composition via Bioelectrical Impedance Analysis (BIA) 
4. Dietary Intake 
5. Physical Activity                                                                                                 
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Height and weight:  Height was measured to the nearest 0.5 inch via a stadiometer 
(Detecto Inc., Webb City, MO), and weight was measured to the nearest 0.5 pound using 
a medical balance-beam scale (Detecto Inc., Webb City, MO).  Subjects were weighed 
while wearing a medical gown to standardize weight measurements for each assessment.  
Height and weight was used to calculate body mass index (BMI) by dividing weight in 
kilograms (kg) by height in meters squared (m2). 
 Resting Energy Expenditure (REE): REE was measured via the dilution technique 
using a Sensor-Medics 2900 metabolic measuring cart (Yorba Linda, CA) and a plastic 
canopy (8, 20).  Subjects were instructed to fast for at least 12 hours the night before 
testing, and to avoid consumption of any over-the-counter medications.  Subjects were 
also instructed to abstain from all vigorous physical activity the day before testing, and to 
transport themselves to the Physical Activity and Weight Management Research Center 
in a vehicle on the morning of the day of testing.  Patients were questioned verbally 
regarding their adherence to the aforementioned pre-testing recommendations prior to 
testing.   
REE was measured between the hours of 7:30-10:30am.  Measurements of each 
patient were performed at week 0 and at week 4.  REE measurements were taken at the 
completion of the subject resting in a supine position in a darkened room for a period of 
thirty minutes.  Following this 30-minute rest period, subjects were placed under the 
canopy in a supine position for a 5-minute steady state measurement period.  Criteria for 
establishing a stable measure of REE was a steady state consisting of five consecutive 
data points with a range of no more than 150 kcal/d which approximates the 5% criteria 
used by Jakicic et. al. (33), that significantly correlated (r = 0.92, p < 0.001) with Foster’s 
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techniques finding steady state at a coefficient of variation (standard deviation/mean) of 
no more than 5% for both VO2 and CVO2 (24, 32).  Data was collected until 5 
consecutive data points meeting the aforementioned criteria were obtained.  The average 
value for volume of oxygen consumed (VO2) and volume of carbon dioxide produced 
(VCO2) from the five consecutive measures were used to calculate REE via software 
using the equation below (54): 
REE = [VO2 L (3.941) + VCO2 L (1.11)] 1440 min/day 
where: 
REE = Resting Energy Expenditure (kcal/d) 
VO2 = Volume of oxygen consumed  
VCO2 = Volume of carbon dioxide produced 
L = Liters 
 
REE is expressed as an absolute value (kcal/d), relative to body weight (kcal/kg/d), and 
relative to lean body mass (kcal/kg LBM/d). 
Body Composition:  Measurement of body composition to determine LBM was 
performed using bioelectrical impedance analysis (BIA) on the same morning as REE 
measurement using a RJL BIA-101A (RJL Systems, Inc., Clinton Twp, MI) four terminal 
impedance analyzer.  This instrument was calibrated throughout the study using a 500-Ω 
resistor according to the procedures recommended by the manufacturer.  BIA was 
assessed with subjects in a supine position.  The skin surface was cleaned using rubbing 
alcohol prior to applying Unitrac disposable electrodes.  Once the alcohol on the skin 
surface was dry, electrodes were placed on the right side of the body at the following four 
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sites: between the styloid processes of the ulna and the radius (E1), distal end of the 
second and third metacarpals (E2), between the lateral malleolus and the medial 
malleolus (E3), and the distal end of the first and second metatarsals (E4).  There was a 
minimum of 8 cm between electrodes E1 and E2, and electrodes E3 and E4.  LBM was 
estimated using a generalized equation and an obesity-specific equation. 
Process measures: 
Physical Activity:  Physical activity was measured using a Paffenbarger Physical 
Activity Questionnaire (40, 41), which examines the previous week of physical activity, 
as illustrated in Appendix E, at 0 and 4 weeks.  This questionnaire required 
approximately 5 minutes to complete. 
Dietary Intake:  Dietary intake was measured in all subjects at 0  weeks using the 
1998 version of the Food Frequency Questionnaire (Block-98 Dietary Data Systems, 
Berkeley, CA) (Appendix F), and on a weekly basis in the Experimental Group using a 
food diary.  ExperimenTal Subjects were requested to fill out the food diary on a daily 
basis, and reviewed by a research staff member on a weekly basis for completion and 
adherence to dietary recommendations.. 
3.4 Experimental interventions 
Subjects were randomly assigned to either an experimental condition or a control 
condition for a period of 4 weeks.    
Dietary intake for control condition: Subjects assigned to the control condition 
were instructed to maintain their current eating and activity behaviors as well as their 
current body weight for the 4-week period.  Dietary intake was measured using the 1998 
version of the Food Frequency Questionnaire (Block-98 Dietary Data Systems, Berkeley, 
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CA) at baseline to assure no difference between groups at baseline.  It was estimated that 
there should be no significant change in body weight in subjects in the control condition.  
Therefore, compliance to dietary intake recommendations in the control condition was 
defined as a change in body weight of no more than 1kg compared to baseline over the 4-
week period of this study. 
Dietary intake for experimental condition: Subjects assigned to the experimental 
condition were instructed to reduce their energy intake to 1200-1500 kcal/d (depending 
on his/her starting weight), which is consistent with guidelines established by the 
American College of Sports Medicine (3), and were instructed to reduce fat intake to 20-
30% of total dietary intake, which is within the established limits for Dietary Reference 
Intakes (DRI) (47).  Subjects were provided with sample meal plans and menus 
developed by registered dietitians to assist them with making appropriate food selections.  
Subjects were instructed to record their eating behaviors in a weekly food diary that was 
reviewed weekly by the intervention staff.  Subjects participating in eating behaviors 
inconsistent with the recommendations for this study were counseled by the registered 
dietitian affiliated with this study. 
Physical Activity:  Physical activity recommendations in the experimental condition 
consisted of 100 minutes of exercise per week (20 minutes per day, 5 days per week).  
The prescribed intensity of the exercise was moderate (<70% of age-predicted maximal 
heart rate), which is the equivalent of brisk walking for most individuals.  Subjects were 
instructed to record their exercise in a weekly exercise diary that was reviewed weekly by 
the intervention staff.  Subjects participating in exercise that is inconsistent with the 
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recommendations for this study were counseled by the study affiliated exercise 
physiologist.   
Treatment Meetings and Contacts:  Subjects were instructed to attend weekly 
group meetings for weeks 1-4. The group intervention meetings were conducted in a 
period of 45-60 minutes.  During these face-to-face interactions the interventionist 
integrated behavioral strategies for adopting and maintaining exercise into the 
intervention.  These behavioral strategies were based primarily on social cognitive theory 
and included the following: self-monitoring, stimulus control, problem solving, relapse 
prevention, social assertion, goal-setting and feedback, and cognitive strategies to 
overcome negative thinking.  These strategies were blended into didactic sessions which 
were lead by a registered dietitian, exercise physiologist, or health psychologist with 
experience conducting weight loss intervention groups.  A list of the lesson topics for the 
group sessions is included in Appendix G. 
3.5 Experimental variables 
 3.51 Primary dependent variables 
1. Resting Energy Expenditure (REE) (kcal/d):  measured at weeks 0 and 4 using 
the methods described in section 3.3. 
2. Changes in relative REE based on changes in total body weight (kcal/kg/d) 
and lean body mass (kcal/kg LBM/d): measured at weeks 0 and 4 
3.52 Secondary dependent variables 
1. Total Body Weight:  measured at weeks 0 and 4  
2. Lean Body Mass: measured at weeks 0 and 4. 
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3.53 Independent variable 
1. Group: Experimental vs. Control: subjects were randomly assigned to either 
the experimental condition (reduced calorie diet of 1200-1500 kcal/d + 100 
minutes of moderate exercise per week) or to the control condition (no change 
in energy intake or exercise). 
3.6 Potential confounding factors 
Dietary compliance:  Efforts were made to control for results influenced by 
subjects in both the experimental and control conditions that may not adhere to the 
dietary protocol.  Efforts to ensure compliance to dietary intake recommendations for 
subjects in the experimental condition required them to: 
1.  Maintain a food diary on a daily basis with daily totals of calories consumed 
2. Maintain a weekly average energy intake of 1200-1500 kcal/d + 10% 
4. Weigh in on a weekly basis at the Physical Activity and Weight Management 
Research Center.  
5. Lose > 1 lb per week 
A staff member met with each experimental subject on a weekly basis to review 
food diaries during which time the subject was also weighed.  A staff member and/or a 
registered dietitian from the University of Pittsburgh counseled subjects who were non-
compliant to the intervention.   
Efforts to ensure compliance to dietary intake recommendations for subjects in 
the control condition required them to: 
1. Weight measured pre and post intervention at the Physical Activity and Weight 
Management Research Center. 
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2. Maintain weight (defined as a change of no more than 1kg) at 0 and 4 weeks of 
the study. 
In addition, subjects in the control condition were offered a delayed intervention 
following their participation in this 4-week study.  This delayed intervention was 
consistent with the intervention provided to the Experimental Group.   
Physical activity:  Subjects who are not adherent to physical activity 
recommendations may also potentially create a bias in the results of the study.  Physical 
activity in both experimental and control subjects were assessed at baseline and at the end 
of the 4-week intervention.  All subjects filled out the Paffenbarger physical activity 
questionnaire on the same day as all other assessments.  Compliance to physical activity 
in the Experimental Group was measured by expressing each subjects exercise in 
minutes, which should equal 100 minutes per week +/- 10%.  Compliance to physical 
activity recommendations in the Control Group was measured by comparing physical 
activity to each individual’s baseline measures.   
3.7 Statistical analysis 
 Thirty subjects utilizing a large effect size and alpha set to 0.05 yields a power of 
0.67.  We were able to recruit 37 subjects which yields a power slightly higher than 0.67.  
The effect size used was based on data available for change in REE from previously 
published investigations.  Wadden et al. (52) demonstrated a decrease in REE of 9.1 + 
4.1% within 5 weeks for an effect size of 2.22.  Hill et al. (29) found a decrease in REE 
of 61.95 + 24.2 kcal/d within 12 weeks for an effect size of 2.56.  Weinsier et al. (53) 
demonstrated a decrease in REE of 393 + 716 kJ/d within 10 days for an effect size of 
0.56.  The average effect size of these three studies is 1.78.   
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Statistical analysis to address the primary hypothesis for this study included a   
two-factor (condition x time) repeated measures analysis of variance (ANOVA).  Group 
(Experimental versus Control) was considered as the between subject factor, with Time 
(0 and 4 weeks) considered as the within subjects factor.  A secondary analysis using a 
two-factor repeated measure ANOVA was conducted based on blocks (BMI values of 
25.0 – 29.9 kg/m2 and 30.0 – 34.9 kg/m2) for the purpose of detecting potential 
differences between these groups.  Data was analyzed based on subjects met criteria for a 
valid resting energy expenditure (REE) test and subjects who did not.  Results are 
presented for both groups.  In order to be included in the analysis for subjects with a valid 
REE measurement, subjects must have met the criteria established for a valid REE test as 
described in section 3.3.   
Significant interactions and main effects were examined using the Tukey post-hoc 
procedure.  The relationship between change in REE and change in lean body mass 
(LBM) was included in the analysis.  Results show correlation coefficients which 
examine the relationship between these two factors 
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Chapter IV  
Results 
 The purpose of this study was to examine the 4-week effect of a low-calorie diet 
and aerobic exercise on absolute (kcal/d) and relative (kcal/kg/d and kcal/kg LBM/d) 
resting energy expenditure (REE) in overweight and obese adults.  Secondary dependent 
variables were body weight and lean body mass.  This study was a randomized clinical 
weight loss intervention with assessments performed at 0 and 4 weeks of participation.  
The primary independent variable was intervention group (Experimental Group versus 
Control Group).  The Experimental Group participated in a 4-week behavioral weight 
loss program to change eating and physical activity behaviors, whereas the Control 
Group was instructed not to reduce body weight or change eating and physical activity. 
4.1 Subject characteristics 
The subjects in this investigation were 37 adults (males = 14 and females = 23).  
Subjects were between the ages of 18 and 55 years old, with a body mass index (BMI) 
ranging from 25.0 to 39.9 kg/m2.  Descriptive statistics are presented in Table 4.1.  There 
were significant differences between BMI groups at baseline for the following 
characteristics: BMI, percent body fat, and resting energy expenditure (REE) relative to 
subjects’ lean body mass (REE/kgLBM/d), and this is illustrated in Table 4.1.  Primary 
outcome analyses were performed with all subjects included. 
A total of 37 subjects were randomized to either the Experimental Group or the 
Control Group.  Of these 37 subjects, 35 subjects provided data at baseline and 4 weeks, 
which yielded a 94.6% retention rate.  Of the 35 subjects who provided data at baseline 
and 4 weeks, there were 4 who did not meet the stringent criteria for achieving a steady 
 28
state REE as described in Chapter 3.  Therefore the total number of subjects who 
provided valid data at baseline and 4 weeks was 31 subjects or 83.8% of subjects. 
Table 4.1 Characteristics of Subjects at Baseline  
Variable BMI (kg/m2) All Subjects (n=37) Experimental  (n=18) Control (n=19) 
Total (25.0-39.9) 42.4+7.8 41.3+8.1 43.5+7.5 
25.0 - 29.9 43.2+8.5 (N=7) 44.3+10.4 (N=4) 41.7+7.1 (N=3) 
30.0 - 34.9 43.1+7.8 (N=20) 40.0+7.5 (N=7) 45.2+7.6 (N=13) 
Age (years) 
35.0 - 39.9 40.1+7.5 (N=8) 41.2+8.5 (N=5) 38.3+6.8 (N=3) 
     
Total (25.0-39.9) 170.0+10.9 168.2+11.8 171.7+9.9 
25.0 - 29.9 171.9+11.2 167.1+8.1 178.3+13.0 
30.0 - 34.9 171.5+10.6 172.7+13.6 170.7+8.6 
Height (cm) 
35.0 - 39.9 164.0+10.5 160.9+7.6 169.2+14.4 
     
Total (25.0-39.9) 93.3+12.4 90.5+13.7 95.8+11.0 
25.0 - 29.9 87.0+13.2 81.6+10.3 94.1+15.3 
30.0 - 34.9 93.2+11.4 92.3+16.6 93.7+8.1 
Body Weight 
(kg) 
35.0 - 39.9 99.3+12.9 94.9+10.2 106.6+15.6 
     
Total (25.0-39.9) 32.6+2.9 32.6+3.2 32.5+2.6 
25.0 - 29.9 29.3+0.8A 29.1+1.0A 29.4+0.7A
30.0 - 34.9 32.1+1.4 A 31.8+1.4A 32.1+1.4A
BMI (kg/m2) 
35.0 - 39.9 36.8+1.3A 36.6+1.2A 37.2+1.7A
     
Total (25.0-39.9) 38.3+6.6 39.2+6.9 37.5+6.3 
25.0 - 29.9 32.0+5.6Ac 32.9+6.6A 30.9+5.1A
30.0 - 34.9 37.8+5.3Bc 38.0+5.3 B 37.6+5.6 
Percent Body 
Fat (% Fat) 
35.0 - 39.9 45.0+3.6AB 45.9+2.3 AB 43.6+5.4A
     
Total (25.0-39.9) 2134+1288 2159+1315 2111.1+1298.7 
25.0 - 29.9 1579+498 1434+532 1772.7+469.3 a
30.0 - 34.9 2076+1231 2527+1555 1764.2+883.9 B
Energy Intake 
(kcal/d) 
35.0 - 39.9 2781+1728 2078+1210 3952.6+2056.5 aB
     
Total (25.0-39.9) 517.3+422.9 460.3+428.9 565.4+423.3 
25.0 - 29.9 393.7+244.2 413.5+301.8 367.3+201.0 
30.0 - 34.9 533.6+435.7 535.6+583.9 532.5+360.6 
Physical 
Activity 
(kcal/d) 
35.0 - 39.9 584.9+530.3 392.2+303.8 906.0+743.1 
     
Total (25.0-39.9) 2067.4+444.9 2030.8+551.2 2098.1+344.3 
25.0 - 29.9 1933.4+306.3 1806.1+321.9 2103.2+224.5 
30.0 - 34.9 2082.8+506.6 2157.7+749.8 2042.5+346.7 
Resting Energy 
Expenditure 
(kcal/d) 
35.0 - 39.9 2146.0+398.5 2033.1+373.7 2334.0+437.7 
     
Total (25.0-39.9) 22.0+2.7  22.2+3.1 21.9+2.5 
25.0 - 29.9 22.2+1.3 22.0+1.4 22.5+1.5 
30.0 - 34.9 22.2+3.4 22.9+4.4 21.8+2.9 
Resting Energy 
Expenditure 
(kcal/kg/d) 
35.0 - 39.9 21.5+1.6 21.3+1.8 21.8+1.4 
     
Total (25.0-39.9) 35.9+4.1  36.6+4.1 35.2+4.1 
25.0 - 29.9 32.9+3.1A 32.9+2.0 32.8+4.8 A
30.0 - 34.9 35.6+3.8B 36.8+4.2 34.9+3.7 
Resting Energy 
Expenditure 
(kcal/kg 
LBM/d) 35.0 - 39.9 39.2+3.3AB 39.4+3.3 38.9+4.0 A
BMI groups with same lower case superscript demonstrate statistically significant at p<0.07 
BMI groups with same upper case superscript demonstrate statistically significant at p<0.05 
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4.2 Change in body weight and BMI 
 
Repeated measures ANOVA (group x time) revealed a significant interaction      
(p < .001) for the change in body weight from baseline to 4 weeks in the Experimental 
Group compared to the Control Group.  This significant interaction effect reflects the 3.3 
+ 1.7 kg weight loss observed in the Experimental Group versus the 0.6 + 1.1 kg weight 
gain observed in the Control Group.  These results are illustrated in Figure 4.1 and shown 
in Table 4.2.  Similar results were demonstrated for the analysis of BMI data with a 
reduction of 1.2 + 0.6 kg/m2 in the Experimental Group versus a 0.2 + 0.4 kg/m2 increase 
in the Control Group (p-value for Group X Time Interaction Effect < .001).  These results 
are shown in Table 4.2.  
 
Figure 4.1.  Change in Body Weight by Group.
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 Table 4.2 Changes in outcomes variables between groups from 0 to 4 weeks.
p-value 
 Outcome 
Variable 
Assessment 
Period 
Experimental 
(n=16) 
Control 
(n=19) Time 
Effect 
Group 
Effect 
Group 
X  
Time 
0 weeks 90.5+13.7 95.8+11.0 <0.001 0.09 <0.001 Body Weight 
(kg) 4 weeks 87.1+13.7 96.4+11.2    
       
0 weeks 32.6+3.2 32.5+2.6 <0.001 0.57 <0.001 Body Mass 
Index (kg/m2 4 weeks 31.4+3.2 32.7+2.7    
       
0 weeks 39.2+6.9 37.5+6.3 <0.001 0.76 <0.01 Percent Body 
Fat (%) 4 weeks 37.4+7.3 37.7+6.4    
       
0 weeks 55.1+11.3 60.1+10.5 0.22 0.16 <0.05 Lean Body 
Mass (kg) 4 weeks 54.5+11.1 60.2+10.7    
       
0 weeks 2030.8+551.2 2098.1+344.3 <0.001 0.27 <0.01 Resting Energy 
Expenditure 
(kcal/d) 
4 weeks 1825.1+494.0 2086.8+348.2    
       
0 weeks 22.2+3.1 21.9+2.5 <0.01 0.80 0.07 Resting Energy 
Expenditure  
(kcal/kg/d) 
4 weeks 20.8+3.5 21.6+2.3    
       
0 weeks 36.6+4.1 35.2+4.1 < .001 0.98 <0.01 Resting Energy 
Expenditure  
(kcal/kg LBM/d) 
4 weeks 33.3+3.7 34.8+2.7    
       
0 weeks 460.3+428.9 565.4+423.3 < .001 .40 <0.01 Physical 
Activity 
(kcal/wk) 
4 weeks 1136.1+613.9 754.3+638.2    
       
 
4.3 Change in Body Composition 
Body composition data are presented in Table 4.2.  Repeated measures ANOVA 
(group x time) revealed a reduction in percent body fat in the Experimental Group (-1.8 + 
1.4%) compared to the Control Group (0.2 + 0.8%) across the 4 week study period 
(interaction effect <0.001).  Analysis of lean body mass (LBM) data also showed a 
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significant decrease in the Experimental Group (-0.6 + 0.9 kg) compared to the Control 
Group (0.2 + 0.9 kg) from baseline to 4 weeks (interaction effect < 0.05).   
4.4 Change in Resting Energy Expenditure 
Repeated measures ANOVA (group x time) revealed a significant interaction 
effect (p<0.01) for the change in REE when comparing the Experimental Group (-205.8 + 
193.0 kcal/d) to the Control Group (-11.4 + 140.6 kcal/d).  These results are shown in 
Table 4.2 and illustrated in Figure 4.2.  A similar pattern of results was found for analysis 
of change in REE relative to body weight with the Experimental Group decreasing by 1.4 
+ 1.9 kcal/kg/d and the Control Group decreasing by 0.3 + 1.5 kcal/kg/d (p-value for 
interaction effect = 0.07) (see Figure 4.3).  A significant interaction effect (p<0.01) was 
also observed for the change in REE relative to LBM with the Experimental Group 
decreasing by 3.3 + 2.9 kcal/kgLBM/d compared to the decrease of 0.4 + 2.6 
kcal/kgLBM/d for the Control Group (see Figure 4.3).   
Examination of the REE data revealed that four subjects, two in the Experimental 
Group and two in the Control Group, did not meet the stringent criteria for achieving a 
steady state REE as described in Chapter 3.  Therefore, data were analyzed removing 
those individuals who did not meet the REE criteria from the analyses and these data are 
presented in Table 4.3.  When data from subjects meeting the REE measurement criteria 
were analyzed, the change in absolute (kcal/d) and relative (kcal/kg/d and kcal/kgLBM/d) 
REE were greater in the Experimental Group compared to the Control Group. 
Data were also analyzed to examine potential gender effects on the changes in 
REE.  These analyses demonstrated that change in absolute REE (kcal/d) and relative 
REE adjusted for change in body weight (kcal/kg/d) and change in lean body mass 
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(kcal/kgLBM/d) were not influenced by gender.  Because of the lack of a significant 
gender effect, these data are not presented.  
 
Figure 4.2. Change in Absolute REE
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 Table 4.3 Comparison of change in REE for subjects who met criteria for a 
valid REE test vs. subjects who did not meet criteria for a valid REE test. 
  All Subjects 
N = 35 
Subjects who met 
criteria 
N = 31 
Subjects who did 
not meet criteria 
N = 4 
Experimental -205.8+193.0 
(N=16) 
-187.2+194.8 
(N=14) 
-335.9+163.9  
(N=2) 
Resting Energy 
Expenditure  
(kcal/d) Control -11.4+140.6 
(N=19) 
-14.3+148.8 
(N=17) 
-13.8+7.8  
(N=2) 
p-value   P < 0.01 P < 0.01 P = 1.00 
     
Experimental -1.4+1.9 
(N=16) 
-1.2+2.0  
(N=14) 
-2.6+0.7  
(N=2) 
Resting Energy 
Expenditure  
(kcal/kg/d) Control -0.3+1.5 
(N=19) 
-0.3+1.6  
(N=17) 
0.1+0.1  
(N=2) 
p-value  P = 0.07 P = 0.19 P < 0.05 
     
Experimental -3.3+2.9 
(N=16) 
-3.2+3.1  
(N=14) 
-4.1+0.4  
(N=2) 
Resting Energy 
Expenditure 
(kcal/kgLBM/d) Control -0.4+2.6 
(N=19) 
-0.5+2.8  
(N=17) 
0.4+0.4  
(N=2) 
p-value  p < 0.01 P < 0.05 P < 0.01 
     
 
 4.5 Change in physical activity 
Repeated measures ANOVA (group x time) revealed a significant interaction      
(p < 0.1) in change in physical activity when comparing the Experimental Group to the 
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Control Group at baseline and at 4 weeks (675.8 + 551.8 vs. 188.9 + 405.1kcal/wk).  
These results are shown in Table 4.2.  
 
4.6 Effect of baseline BMI on changes in weight, body composition, and REE 
 Results for each variable were analyzed based on baseline BMI with subjects 
categorized as 25-29.9 kg/m2, 30-34.9 kg/m2, and 35-39.9 kg/m2.  Results indicated that 
both change in body weight and change in REE/kgLBM/d were significantly influenced 
by category of baseline BMI (p<0.05).  These results are presented in Table 4.4. 
Table 4.4 Changes in outcomes variables between groups based on 
baseline body mass index (BMI) category.
p-value 
 Outcome 
Variable 
Baseline 
BMI 
Category 
(kg/m2) 
Experi-
mental 
(n=16) 
Control 
(n=19) Group 
Effect 
BMI 
Effect 
Group 
X  
BMI 
25.0-29.9 -3.2+0.6 -0.2+0.9 < .05 < .05 .78 
30.0-34.9 -3.3+2.4 0.7+1.2    
 Body Weight (kg) 
35.0-39.0 -3.5+1.1 1.1+0.9    
        
25.0-29.9 -1.2+0.3 -0.2+0.9 < .001 .76 .46 
30.0-34.9 -1.1+0.8 0.2+0.4    
Body Mass Index 
(kg/m2
35.0-39.0 -1.4+0.5 0.4+0.3    
       
25.0-29.9 -1.9+0.5 0.5+1.3 < .001 .91 .40 
30.0-34.9 -2.0+2.0 0.3+0.8    
Percent Body Fat 
(%) 
35.0-39.0 -1.3+0.5 -0.3+0.5    
       
25.0-29.9 -0.7+1.0 -0.6+0.7 < .05 .27 .23 
30.0-34.9 -0.3+1.1  0.2+0.9    
Lean Body Mass 
(kg) 
35.0-39.0 -0.8+0.4 -0.9+0.8    
       
25.0-29.9 -138.9+123.6 -4.2+135.5 < .001 .11 .61 
30.0-34.9 -139.2+164.4 2.6+129.1    
Resting Energy 
Expenditure 
(kcal/d) 35.0-39.0 -352.6+220.3 -78.8+226.6    
       
25.0-29.9 -0.8+1.4 -0.1+1.7 .13 .08 .64 
30.0-34.9 0.3+1.8 -0.1+1.4    
Resting Energy 
Expenditure  
(kcal/kg/d) 35.0-39.0 -2.9+1.9 -1.1+2.2    
       
25.0-29.9 -2.1+1.8 -0.1+2.1 < .05 < .05 .71 
30.0-34.9 -2.1+1.7 -0.1+2.4    
Resting Energy 
Expenditure  
(kcal/kg LBM/d) 35.0-39.0 -6.0+3.4 -2.2+4.2    
       
25.0-29.9 476.1+166.4 31.3+189.0 < .05 .49 .17 
30.0-34.9 646.6+587.1 322.6+397.7    
Physical Activity 
(kcal/wk) 
35.0-39.0 876.5+715.9 -232.7+268.2    
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Table 4.5 Correlates of demographic variables with Resting Energy Expenditure. 
Resting Energy Expenditure (kcal/d) 
Variable BMI 
(kg/m2) 
All Subjects 
(n=35) 
Experimental 
(n=16) 
Control 
(n=19) 
  Baseline 4 Weeks Baseline 4 Weeks Baseline 4 
Weeks 
Total 
(25.0-39.9) 
0.82** 0.77** 0.88** 0.72** 0.74** 0.78** 
25.0 - 29.9 0.93**  
(n=7) 
0.99**  
(n=7) 
0.96* 
(n=4) 
1.00**(n=4) 0.99 
(n=3) 
0.99 
(n=3) 
30.0 - 34.9 0.77**  
(n=20) 
0.73** 
(n=20) 
0.86**  
(n=7) 
0.79* 
(n=7) 
0.62* 
(n=13) 
0.64* 
(n=13) 
Body 
Weight 
(kg) 
35.0 - 39.9 0.95**  
(n=8) 
0.93**  
(n=8) 
0.95* 
(n=5) 
0.77 
(n=5) 
0.96 
(n=3) 
1.00*** 
(n=3) 
        
Total 
(25.0-39.9) 
0.84** 0.89** 0.89** 0.90** 0.78** 0.89** 
25.0-29.9 0.93** 
(n=7) 
0.94** 
(n=7) 
0.95***
(n=4) 
0.90  
(n=4) 
0.98 
(n=3) 
1.00** 
(n=3) 
30.0-34.9 0.86** 
(n=20) 
0.91** 
(n=20) 
0.93** 
(n=7) 
0.96** 
(n=7) 
0.80** 
(n=13) 
0.86** 
(n=13) 
Lean 
Body 
Mass 
(kg) 
35.0-39.9 0.90**  
(n=8) 
0.93** 
 (n=8) 
0.90* 
(n=5) 
0.71 
(n=5) 
0.94 
(n=3) 
1.00* 
(n=3) 
 
Change in Resting Energy Expenditure (kcal/d) 
Variable BMI (kg/m2) All Subjects 
(n=35) 
Experimental 
(n=16) 
Control 
(n=19) 
Total (25.0-39.9) 0.41* -0.16 0.19 
25.0 - 29.9 0.48 (n=7) 0.31 (n=4) -0.33 (n=3) 
30.0 - 34.9 0.27 (n=20) -0.35 (n=7) 0.18 (n=13) 
Change in  
Body 
Weight 
(kg) 35.0 - 39.9 0.56 (n=8) -0.24 (n=5) 1.00*** (n=3) 
 
     
Total (25.0-39.9) 0.44** 0.46 0.15 
25.0-29.9 0.47 (n=7) 0.42 (n=4) 0.70 (n=3) 
30.0-34.9 0.45* (n=20) 0.83* (n=7) 0.06 (n=13) 
Change in 
Lean 
Body 
Mass (kg) 35.0-39.9 0.58 (n=8) 0.45 (n=5) 0.85 (n=3) 
* indicates correlation statistically significant at p<0.05 
**indicates correlation statistically significant at p<0.01 
***indicates correlation statistically significant at p<0.06 
 
4.7 Correlates of REE 
 
4.71 Correlations between REE and body weight 
Table 4.5 displays the correlation coefficients representing the relation between 
REE and body weight.  REE was significantly correlated with body weight at baseline 
and at 4 weeks when analyzed for the Experimental Group (baseline: r = .88; 4 weeks: r= 
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.72; p < 01) and the Control Group (baseline: r = .74; 4 weeks: r = .78; p < .01).  When 
the groups were combined similar results were shown (baseline: r = 0.82; 4 weeks: r = 
0.77; p < .01).  Data by BMI category are also presented in Table 4.5. 
  Table 4.5 displays the correlation coefficients representing the relation between 
change in REE and change in body weight.  When the Experimental and Control groups 
were combined, the change in REE was significantly correlated with the change in body 
weight (r = .41, p < .05).  However, the change in REE was not significantly correlated 
with change in body weight when analyzed separately for the Experimental Group (r =     
-0.16, p > .05) or the Control Group (r = 0.19, p > .05).  Data by BMI category are also 
presented in Table 4.5. 
4.72 Correlations between REE and lean body mass  
Table 4.5 displays the correlation coefficients representing the relation between 
REE and lean body mass (LBM).  REE was significantly correlated with LBM at baseline 
and at 4 weeks when analyzed for the Experimental Group (baseline: r = .89; 4 weeks:   
r= .90; p < 01) and the Control Group (baseline: r = .78; 4 weeks: r = .89; p < .01).  When 
the groups were combined similar results were shown (baseline: r = 0.84; 4 weeks:           
r = 0.89; p < .01). Data by BMI category are also presented in Table 4.5. 
Table 4.5 displays the correlation coefficients representing the relation between 
change in REE and change in lean body mass (LBM).  When the Experimental and 
Control Groups were combined, change in REE was significantly correlated with change 
in LBM (r = .44, p < .01). Change in REE was not significantly correlated with change in 
LBM when analyzed for the Experimental Group (r = -0.46, p > .05) and the Control 
Group (r = -0.18, p > .05).  Data by BMI category are also presented in Table 4.5.  
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Chapter V  
Discussion 
5.1  Introduction 
Weight loss programs using low-calorie diets with and without the inclusion of 
aerobic exercise have been shown to reduce resting energy expenditure (REE) (7, 15, 28, 
34, 52), and these studies have partially attributed this reduction in REE to the reduction 
in total body weight and loss of lean body mass over the intervention period.  However, 
few studies have examined these factors during the initial few weeks of weight loss.  This 
investigation aimed to assess the effect of weight loss achieved through the combination 
of a reduction in energy intake and increase in aerobic exercise on change in resting 
energy expenditure over the initial 4 weeks of a weight loss intervention.  Therefore, the 
primary aims of this investigation were to evaluate the effect of a low-calorie diet 
combined with aerobic exercise over a period of 4-weeks on resting energy expenditure, 
body weight, and lean body mass.  Further, we aimed to examine the relationship 
between change in REE and in both total body weight and lean body mass. 
5.2  Conclusions 
 Body Weight.  Results of this study demonstrated significant (p < .001) weight 
loss in the Experimental Group compared to the Control Group (-3.4 + 13.7 kg vs. 0.6 + 
11.1 kg) over the 4-week period, supporting our initial hypothesis.  This approximates a 
mean weight loss of 1.9 lbs/wk (0.85 kg/wk) in the Experimental Group.  This magnitude 
of weight loss is similar to the magnitude resulting from interventions implementing a 
similar energy intake (1200kcal/d) (24, 51, 52).  For example, Wadden et al. reported 
average weight losses of 1.45 kg/week and 0.82 kg/week in response to interventions 
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with similar recommendations in diet and exercise (51,52).  Moreover, the average 
weight loss per week from this study is within the recommended guidelines for weight 
loss established by the American College of Sports Medicine (ACSM) of 1-2 pounds per 
week (3). 
 Although our study did not have a valid measure to examine the change in dietary 
intake across the intervention and control periods, data from other studies may provide 
some understanding of the energy intake in this study.  For example, weight loss in this 
current study was similar to the weight loss reported by Wadden et. al. ( 1990, 1994) in 
which energy intake was prescribed at approximately 1200 kcal/d (51, 52).  In a similar 
manner, the current study prescribed energy intake at 1200-1500kcal/d.  This, this may 
indicated that energy intake was similar across these studies.  However, it would still be 
advantageous to include a valid and reliable measure of energy intake in future studies 
when examining the change in REE with weight loss. 
Body Composition.  Results of this study demonstrated a significant (p < .001) 
reduction in percent body fat in the Experimental Group compared to the Control Group    
(-1.9 + 7.1% vs. 0.2 + 6.3%) as presented in Table 4.2.  The results in response to the 
intervention are comparable to other studies of this approximate duration.  For example, 
Henson et al. reported a reduction in percent body fat of 2.7% and 1.1% in response to a 
6-week intervention combining energy restriction with and without exercise, respectively 
(30).  In addition, the current study also demonstrated a significant (p < .05) reduction in 
lean body mass in the Experimental Group compared to the Control Group (-0.6 + 11.1 
vs. 0.1 + 10.6) (see Table 4.2).  These findings do not support the hypothesis that there 
would be no significant reduction in lean body mass in the Experimental compared to the 
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Control Group.  In a study of similar duration (3 weeks) but with a more aggressive 
dietary recommendation that included only 800 kcal/d, Henson et al. reported no 
significant change in LBM (28).  However, in a study of somewhat longer magnitude, 
deGroot et al. reported a reduction in LBM of 3.2kg in response to 8 weeks of a diet 
consisting of 800 kcal/d diet (16).   
A potential limitation of this study when examining the change in body 
composition is the use of bio-electrical impedance analysis (BIA).  This technique may 
have limitations for accurately assessing body composition in response to weight loss in 
overweight adults when compared to other methods.  Although BIA has been found to be 
a valid method of measurement for assessing body composition when compared to 
hydrostatic weighing (r= 0.77), the standard error of estimate (SEE) was found to be 
slightly higher (4.2%) than the conventionally accepted error (3.8%)  established by 
Lohman et. al. (36) for field applicable methods (19,36).  Thus, for future studies, the use 
of other methods of assessing body composition such as dual energy x-ray 
absorptiometry (DEXA) which has been shown to offer an SEE < 3%, may offer a more 
accurate measure of the various components of body composition (42).  This may allow 
for an enhanced understanding of the effects of weight loss on changes in the different 
compartments of body composition (e.g., lean tissue, fat tissue, water, bone mineral, etc. 
Previous research appears to demonstrated that the inclusion of aerobic training, 
resistance training, or the combination of both to a weight loss intervention consisting of 
caloric intakes ranging from 500-1500kcal/d does not significantly influence change in 
lean body mass (17, 29, 39, 50).  These data appear to demonstrate that LBM is reduced 
with weight loss; however, the reported percentage of weight lost from LBM appeared to 
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vary across different studies with a range from 10% to 43% of total weight lost from 
LBM (need references here).  This range of change in LBM may be a result varying 
caloric intakes and exercise recommendations across studies.  Hill et. al. reported 
significant differences between LBM loss in subjects prescribed a diet (800 kcal/d) plus 
walking program vs. subjects who were prescribed diet only (800 kcal/d).  The diet only 
subjects lost 43 +/- 4% of weight from lean body mass vs. a 26 +/- 4% loss in lean body 
mass in the diet plus exercise group.  (30).  This may warrant further investigation 
comparing varying levels of caloric restriction with aerobic and/or resistance exercise.   
 Resting Energy Expenditure.  Results of this study also demonstrated a 
significant reduction in absolute resting energy expenditure (REE) in the Experimental 
Group compared to the Control Group, with the Experimental Group having a reduction 
in REE of approximately 205 kcal/d  (see Table 4.2).  These findings support the 
hypothesis that weight loss would result in a significant reduction in REE in response to 
weight loss when compared to a weight stable Control Group.  These findings are similar 
to those found in other published studies with similar methods.  For example, Wadden et 
al. reported a reduction of 193 kcal/d in REE after 5 weeks of a 1200 kcal/d intake (28, 
52).  These findings may have clinical significance.  For example, if physical activity and 
energy intake were to remain constant, a difference in total daily energy expenditure of 
approximately 200 kcal/d would result in a slowing of weight loss by approximately 0.41 
pounds per week or approximately 1.75 pounds per month assuming 3,500 kcal is equal 
to one pound of body weight.  This may explain the slowing of weight loss over time that 
is typically observed in clinical weight management programs.  Therefore, to compensate 
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for this reduction in REE, programs may need to continuously adjust physical activity 
and energy intake levels to maintain a constant rate of weight loss. 
 Results of this study demonstrate a trend for the Experimental Group to have a 
greater reduction in REE relative to total body weight (kcal/kg/d) compared to the 
Control Group (-1.4+ 3.3 kcal/kg/d vs. –0.3 + 2.4 kcal/kg/d).  When examining change in 
REE relative to LBM (REE/kgLBM/d), the results demonstrated a significant (p < .01) 
reduction in Experimental Group compared to the Control Group (-3.3 + 3.9 
kcal/kgLBM/d vs. –0.4 + 3.4 kcal/kgLBM/d).  These reductions in REE expressed as 
kcal/kg/d and kcal/kgLBM/d are similar to results reported in other studies.  For example, 
Henson et al. reported a similar magnitude of reduction of 1.4 kcal/kg/d and 3.4 
kcal/kgLBM/d over a 3 week period in response to an 800 kcal/d diet (28).  Our findings 
support the hypothesis that overweight and obese males and females would have a 
reduction in REE relative to change in body weight (kcal/kg/d) and LBM (kcal/kg/d) in 
the Experimental Group when compared to the Control Group. 
Correlations.  Results of this study demonstrated that REE was significantly 
correlated with body weight at baseline and at 4 weeks when analyzed separately for both 
the Experimental and Control groups as well as when the groups were combined, with 
correlations ranging from 0.72 to 0.88 (see Table 4.5).  These results appear to be similar 
to the correlations between body weight and REE reported by others.  For example, 
Nieman et al. (39) reported correlations of approximately r=0.72 between REE and body 
weight when assessed weekly for a period of 5 weeks.  The current study also 
demonstrated that change in REE was modestly correlated with change in body weight 
(r=0.41, see Table 4.5).  This correlation is somewhat lower than the r=0.76 correlation 
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between change in weight and change in REE reported by Weyer et al. (55).  This 
potential difference in findings may be explained by the fact that Weyer et al. examined 
this question in response to weight gain, whereas the current study examined this 
question in response to weight loss.  Therefore, this may warrant further investigation. 
The results of this study also demonstrated that REE was significantly correlated 
with LBM at baseline and at 4 weeks with correlations ranging from 0.78 to 0.90 as 
presented in table 4.5.  However, the correlation between change in LBM and change in 
REE was more modest at r=0.44.  By comparison, Elliot et al. (18) reported a correlation 
of r=0.89 between REE and LBM following a 16-week diet consisting of 300 kcal/d diet 
for 8 weeks followed by a 1100-1400 kcal/d diet for an additional 8 weeks.  The modest 
correlation between the change in LBM and change in REE reported in the current study 
may suggest that the initial reduction in REE is not completely explained by the reduction 
in LBM.  Thus, this may warrant further investigation to explain additional physiological 
and metabolic mechanisms contributing to the reduction in REE in the early stages of 
weight loss.  
There may be additional physiological mechanisms that may impact REE.  Hill et. 
al. reported that thyroid hormone triiodothyronine T3 declined significantly (p< .05) 
during a weight loss intervention including a 800kcal/d diet recommendation.  Reduction 
in T3 levels may reduce resting metabolic rate since a symptom of hypothyroidism is a 
reduction in T3 levels.  In addition, food restriction has been shown to increase levels of 
neuropeptide Y (NPY) which has been shown to reduce energy expenditure (46).  Food 
restriction also appears to reduce levels of the hormone leptin in the body, which has also 
been shown to slow REE (46).  Another potential factor contributing to reduction in REE 
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is reduced levels of uncoupling proteins 2 (UCP2) and 3 (UCP3) (14, 23, 25).  Although 
the function of these homologs is not completely understood, studies suggest that their 
potential to uncouple mitochondrial respiration in model systems indicates that they may 
increase metabolic rate and fuel utilization.  Of importance is that there appears to be a 
genetic influence on UCP2 and UCP3 (14, 23, 25), which may influence the effect of 
these factors on metabolisms and body weight regulation. 
5.3  Limitations and Future Research 
This investigation is not without limitations which could impact the application of 
the observed results.  The following recommendations should be considered for future 
research: 
1. This study examined the change in REE in response to weight loss over a 4-week 
period.  While providing data on the initial response of REE in response to a 4-
week intervention, this provides limited data on the time-course of change in REE 
over a longer period of time.  Thus, future research should examine the time-
course of the change in REE in response to weight loss over a longer observation 
period. 
2. This study had a sufficient sample size to compare the Experimental and Control 
groups for the primary outcomes.  However, the sample size was inadequate to 
sufficiently examine the effect of other demographic characteristics on REE in 
response to weight loss.  For example, when separated by BMI category the 
sample sizes in many of these categories were relatively small, which may limit 
the interpretation of these analyses due to insufficient statistical power.  Thus, 
future studies should consider recruiting subjects in sufficient numbers to allow 
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for additional analyses based on BMI, age, gender, and other demographic 
characteristics. 
3. This study used the combination of energy restriction and physical activity within 
the weight loss intervention.  While effective for weight loss, this approach does 
not allow for the examination to determine if these intervention components 
would have differing effects on the outcomes of this study (REE, weight, body 
composition).  These factors may affect the relationship between these outcome 
variables, which may be impacted by differing physiological and metabolic 
mechanisms.  Future studies should examine the independent and combined 
effects of these intervention strategies on changes in REE in response to weight 
loss. 
4. There are potential limitations in the measurements used in this study.  For 
example, BIA was used to assess body composition, and there may be limitations 
to this technology when examining body composition in overweight and obese 
adults (19,36).  Moreover, physical activity and dietary intake were assessed using 
self-report, and it has been demonstrated that overweight adults inaccurately 
report their level of exercise and dietary intake (35).  Therefore, future studies in 
this area should consider the use of objective measurement techniques that have 
been shown to have acceptable validity and reliability. 
5. Energy intake in this study was assessed at baseline, but was not assessed at the 
conclusion of the 4-week intervention period.  Thus, this study is unable to 
determine the effect of changes in dietary intake on observed changes in body 
weight, body composition, or REE.  Future studies should include a valid and 
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reliable measurement of dietary intake periodically throughout the intervention 
period. 
6. This study did not measure additional physiological or metabolic mechanisms that 
may contribute to changes in body weight, body composition, or REE.  Future 
studies should include these key measures to better understand the impact of an 
intervention on these factors and how these factors contribute to body weight 
control and REE. 
5.4  Summary 
The purpose of this study was to examine the 4-week effect of a low-calorie diet 
and aerobic exercise on absolute (kcal/d) and relative (kcal/kg/d and kcal/kg LBM/d) 
resting energy expenditure (REE) in overweight and obese adults.  Secondary aims 
included the examination of change in body weight and lean body mass (LBM) as well as 
the correlation of these variables with change in REE.  Results of this study demonstrated 
that as a result of a 4-week weight loss regimen combining a low-calorie diet and 
moderate aerobic exercise, there was a significant reduction in REE (kcal/d) and REE 
relative to LBM (kcal/kgLBM/d), with a trend toward statistical significance in REE 
relative to total body weight (kcal/kg/d).  The modest correlations between the change in 
REE and change in body weight and LBM suggest that additional factors may contribute 
to alterations in REE in response to weight loss.  Future studies should further examine 
these important research questions related to body weight regulation and the contribution 
of energy expenditure.  
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University of Pittsburgh 
Institutional Review Board 
IRB #0511001 
 
DESCRIPTION: 
 
The number of overweight and obese adults in the United States has been increasing at a 
rapid rate. Both reducing your food intake and increasing your exercise are important components 
of a weight loss program. This study will examine factors that may influence your use of weight 
loss strategies and how these factors affect your weight loss process, and the short-term effects of 
reduced calorie intake on resting energy expenditure (REE) in overweight and moderately obese 
women.  Resting Energy Expenditure (REE) is the number of calories you burn in energy to 
allow your body to perform basic functions such as breathing, having your heart beat, and other 
functions to sustain life.    
You are being invited to take part in this research study because you are within the body 
weight range for this study, have not lost more than 10% of your body weight within the past 
year, and do not have any medical conditions that would prohibit you from participating in 
moderate to vigorous activity. People invited into this study have to be men or women between 
18-55 years of age. Women participants cannot be pregnant, and if you are a woman you will be 
required to accurately report whether you are pregnant to the investigators prior to beginning this 
study and during the study if your status should change. This study is being performed on a total 
of 50 individuals at the University of Pittsburgh. 
If you decide to take part in this research study, you will undergo the following 
procedures that are not part of your standard medical care: 
 
Screening Procedures:
 Procedures to determine if you are eligible to take part in a research study are  
called “screening procedures”. For this research study, the screening procedures include:  
 
You will complete a physical activity readiness questionnaire (PAR-Q), and this  
will take approximately 5 minutes to complete. You will also complete a detailed  
medical history, and this will take approximately 20 minutes to complete. These  
questionnaires will allow the investigators to determine if you have any  
significant medical condition that would indicate that eligibility is unsafe for you.  
 
If you are a woman and report a pregnancy during the previous six months, report that 
you are currently pregnant, that you plan to become pregnant in the next six months, or if 
you become pregnant during the study period then you will not be eligible to participate 
or continue participating in the study. If you are pregnant you will be excluded from this 
study since the study requirements of decreasing the amount and types of food that you 
eat and increasing your level of physical activity may be harmful to your health and the 
health of your unborn child.  
 
 
 
 
Participant’s Initials____ 
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You will also be required to provide written clearance from your personal physician 
before starting this study. You will be provided a Physician Consent form and it will be 
your responsibility to have this form signed by your personal physician and returned to 
the principal investigator prior to participating in the experimental procedures of the 
weight loss program described below. 
 
Experimental Procedures:
 If you qualify to take part in this research study, you will undergo the following 
experimental procedure assessments which will be conducted on weekdays during the hours of 
7:30 AM to 10:30 AM at the University of Pittsburgh’s Physical Activity and Weight 
Management Research Center:  
 
Body Weight and Height:  Your body weight will be measured in private room using a 
standard medical scale.  Your height will be measured with a ruler that is attached to a 
flat wall.  These will be measured at 0, 12, and 24 weeks during this study.  
 
Exercise, Dietary Patterns, and Factors that Influence Behavior Change:  You will 
complete questionnaires about the amount of exercise that you do in the presence of study 
personnel which will take approximately 20 minutes. You will also be given 
questionnaires to take home and complete on your own time. These questionnaires will 
include information about the amount and types of foods that you eat, your mood, general 
health, and other factors that may affect your exercise and eating behaviors. You will be 
required to complete approximately 12 different questionnaires at 0, 12, and 24 weeks 
during this study.  It is estimated that you will be able to complete these questionnaires in 
approximately 60-90 minutes.  In addition, you will complete 1 questionnaire at 0, 4, 8, 
12, 16, 20, and 24 weeks, and 1 questionnaire only at week 24.  It is estimated that you 
will able to complete these additional questionnaires in approximately 5-10 minutes.    
Note:  One of the questionnaires that you will complete will provide information 
 about your mood and if you have symptoms of depression. If it is determined that  
you have symptoms of depression then you will be notified immediately and will  
be referred to your primary care physician for follow-up screening. If this is  
extreme and requires immediate medical care, and you are in the presence of the  
study investigators, you will be transported to the hospital.   
 
Resting Energy expenditure (REE):  Resting Energy Expenditure (REE) is the number of calories 
you burn in energy to allow your body to perform basic functions such as breathing, having your 
heart beat, and other functions to sustain life.  On the morning of the test you will need to be 
transported to the research center by car, mass transportation such as a bus, or other from of 
motorized transportation.  You will also be required not to participate in exercise or other 
vigorous forms of activity for at least one day (24 hours) before completing this measurement.  
You will also be required to avoid all food and beverages (other than water), and over-the-counter 
medications for 12 hours before this measurement. 
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 After arriving at the research center on the day of this test, you will lie in a 
resting position for 30 minutes.  The air that you breathe out (exhale) will then be 
measured for an additional 15-30 minutes using a metabolic cart.  A metabolic cart is a 
machine that allows investigators to determine how much air you breathe in and out, and 
how much of that is oxygen and carbon dioxide.  This information will allow the 
investigators to determine how many calories you burn if you were to remain in a resting 
position all day.  This will require that a plastic canopy be placed over your head as this 
will allow all of the air you breathe out to be analyzed.  It is important for you to realize 
that you will not breathe any special mixes of air, but rather will breathe normal room air.  
This test just allows for that air to be measured to determine your resting energy 
expenditure. 
 This test will be performed twice, one time before you start the study and then 4 
weeks after the study begins.  This test will require approximately 60 minutes to 
complete for each measurement period. 
 
Body composition:  Body composition is the amount of fat weight and lean weight 
(muscle and bone) that you have on your body.  Your body composition will be measured 
using a technique known as Bioelectrical Impedance Analysis (BIA).  This procedure 
requires that a small electrode be placed on your hand, wrist, ankle, and foot.  A low-
level signal that is not harmful to you and that you will not feel is transmitted between the 
electrodes.  There is no harm or risk associated with this procedure.  This test will require 
approximately 15 minutes to complete at each measurement period.  This test will be 
performed twice, one time before you start the study and then 4 weeks after the study 
begins. 
  
Description of the Weight Control Program:   
If you consent to participate in this study you will be assigned to one of two weight loss 
interventions.  Your assignment to the weight loss intervention will be random, which means that 
you can not choose your group but rather this is determined in a method that is similar to flipping 
a coin.  These weight loss groups are: 1) Weight Loss Intervention Group, or 2) Delayed Weight 
Loss Intervention Group.  These weight loss groups are described below. 
1.  Weight Loss Intervention Group:  If you are assigned to the weight loss intervention 
group you will receive the following 
  a.) Group Meetings and Contacts:  You will attend a total of 24 weekly group  
  meetings over 6 months at the University of Pittsburgh’s Physical Activity and  
  Weight Management Research Center. You will not have the ability to select the  
  day or time of the group meetings, but rather the group meetings will be held ad a 
  set day and time and this information will be provided to you prior to you 
  agreeing to participate in this study. Each group meeting will last 45 to 60  
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 minutes.  These weekly meetings will be held on the same night every week, and 
the group will have approximately 20 to 25 members that will be dieting and 
participating in exercise to lose weight. If you decide to discontinue your 
participation in this weight loss program you will need to provide written 
notification to the principal investigator listed on page 1 of this document.  
b) Diet:  It will be recommended that you reduce the amount of food that you eat 
and change some of your food choices.  This will result in you eating few 
calories and reducing the amount of fat that you eat.  If you are less than 200 
pounds, you will be placed on a 1200 calorie per day diet.  If you are 200 pounds 
or greater, you will be placed on a 1500 calorie per day diet.  You will also be 
taught how to decrease the amount of fat that you eat, and will be encouraged to 
decrease fat intake to 20-30% of your total calories. You will record the food that 
you eat in a diary, and this will be returned to the investigators weekly. 
c) Exercise:  It will be recommended that you increase your participation in regular 
exercise.  You will be instructed to exercise 5 days per week, with the walking 
duration on each day increasing from 20 to 40 minutes during the first 12-weeks 
of the program, and you will maintain this level of exercise throughout the 
remainder of the program.  You will be allowed to divide your exercise into 
periods of at least 10 minutes to make it easier for you to exercise.  You will 
exercise at an intensity of 60-70% of your maximal capacity, which is the 
equivalent of taking a brisk walk for most individuals.  Brisk walking will be 
recommended, however you can self-select to participate in other forms of 
activity for your exercise provided you follow the guidelines described above.  
You will record your exercise in a diary that is returned to the investigators 
weekly. 
2.  Delayed Weight Loss Intervention Group:  If you are assigned to the Delayed Weight 
Loss Intervention group you will receive the following: 
a) Group Meetings, and Contacts:  Following your baseline assessment you will 
participate in a 4 week period where you will be instructed to maintain your 
current eating and exercise behaviors that will allow you to maintain your body 
weight.  Following this 4-week period, you will then attend a total of 24 weekly 
group meetings over 6 months at the University of Pittsburgh’s Physical Activity 
and Weight Management Research Center.  You will not have the ability to select 
the day or time of the group meetings, but rather the group meetings will be held 
at a set day and time and this information will be provided to you prior to you 
agreeing to participate in this study.  Each group meeting will last 45 to 60 
minutes.  These weekly meetings will be held on the same night every week, and 
the group will have approximately 20-25 members that will be dieting and 
participating in exercise to lose weight.  If you decide to discontinue your 
participation in this weight loss program you will need to provide written 
notification to the principal investigator listed on page 1 of this document. 
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b) Diet:  Following your baseline assessment you will participate in a 4 week period 
where you will be instructed to maintain your current eating behaviors that will 
allow you to maintain your body weight.  Following this 4-week period, it will be 
recommended that you reduce the amount of food that you eat and change some 
of your food choices.  This will result in you eating few calories and reducing the 
amount of fat that you eat.  If you are less than 200 pounds, you will be placed on 
a 1200 calorie per day diet.  If you are 200 pounds or greater, you will be placed 
on a 1500 calorie per day diet.  You will also be taught how to decrease the 
amount of fat that you eat, and will be encouraged to decrease fat intake to 20-
30% of your total calories.  You will record the food that you eat in a diary, and 
this will be returned to the investigators weekly. 
c) Exercise:  Following your baseline assessment you will participate in a 4-week 
period where you will be instructed to maintain your current exercise behaviors 
that will allow you to maintain your body weight.  Following this 4-week period, 
it will be recommended that you increase your participation in regular exercise.  
You will be instructed to exercise 5 days per week, with the walking duration on 
each day increasing from 20 to 40 minutes during the first 12-weeks of the 
program, and you will maintain this level of exercise throughout the remainder of 
the program.  You will be allowed to divide your exercise into periods of at least 
10 minutes to make it easier for you to exercise.  You will exercise at an intensity 
of 60-70% of your maximal capacity, with is the equivalent of taking a brisk 
walk for most individuals.  Brisk walking will be recommended, however you 
can self-select to participate in other forms of activity for your exercise provided 
you follow the guidelines described above.  You will record you exercise in a 
diary that is returned to the investigators weekly. 
 
RISKS and BENEFITS: 
 The possible risks of this research study may be due to the exercises that you will be 
performing. 
 
Risks of Exercise:  There are risks associated with participating in an exercise program.  During 
exercise, you may experience a serious cardiac event (i.e., heart attack), an arrhythmia (i.e. 
irregular heart beat), or chest pain.  The risk of a serious cardiac event, arrhythmia, or chest pain 
would be infrequent (less than 10% or less than 10 persons out of 100 people).  In addition, 
during exercise, you may experience an increase in heart rate, an increase in blood pressure, 
shortness of breath, or general fatigue.  The risk of increased heart rate and blood pressure, 
shortness of breath, or general fatigue is common (greater than 10% or more than 10 out of 100 
people.  Because the exercise sessions that you will be asked to do will not be supervised by the 
staff, the staff cannot provide medical assistance to you in the event of an emergency during these 
exercise sessions. 
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Risks of Reducing Your Caloric and Fat Intake:  Consuming a moderately low fat and low calorie 
diet appears to be safe and effective for weight loss.  However, if you reduce your calorie or fat 
intake below recommended levels you may experience dry skin and thinning of your hair.  This is 
common and occurs in 1% to 25% of people (1 to 25 out of 100 people).  You may also 
experience problems with your gall bladder like Cholelithiasis (also known as gallstones). 
Symptoms for this condition include abdominal pain or back pain.  If severe, surgery may be 
required to remove your gall bladder. This is infrequent and occurs in less than 1% of people (less 
than 1 out of 100 people). 
 
Risk Associated with Completion of Questionnaires:  You may experience non-physical risks 
such as boredom, frustration, stress, and time constraints when completing the questionnaires. 
The risk of this happening to you is common because this occurs in more than 10% of people 
(more than 10 out of 100 people). To minimize the occurrence of these risks you will be allowed 
to take the questionnaires home and complete them at your leisure provided they are returned to 
the investigators by the date specified to you. 
 
Risk Associated with Participating in the Group Intervention:  Attending group sessions has been 
shown to be effective for weight loss.  However, attendance at these sessions may involve you 
sharing information about yourself and your weight loss efforts to other group members.  You can 
elect not to share this private information about yourself to other group members.  Members of 
the group will be instructed to keep all information shared in the group sessions confidential.  
However, because the investigators can not guarantee that all group members will keep this 
information confidential, there is risk that group members may share information about the group 
session with individuals not participating in this study.  The risk of this happening to you is 
common because this may occur in more than 10% of people (more than 10 out of 100 people).   
 
Risk Associated with measurement of Body Composition using BIA:  It is infrequent that you 
will feel any discomfort as a result of participating in the body composition measurement using 
the BIA (occurs in less than 10% of people or less than 10 out of 100 people). 
 
Risk Associated with Measurement of Resting Energy Expenditure (REE): Risks associated with 
measurement of REE may include mild discomfort as a result of having the plastic canopy placed 
over your head.  This is common to occur during the assessment (occurs in more than 10% of 
people or more than 10 out of 100 people), but bay be more common in those individuals who are 
uncomfortable in enclosed areas. 
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There are also possible benefits of this research study that may be due to the exercises 
that you will be performing and the diet that will reduce the amount and types of foods that you 
will be eating.  However, there is no guarantee that any or all of these changes will occur as a 
result of you participating in this study. 
 
Benefits of Exercise:  The benefits of participation in an exercise program have been shown to 
include improvements in physical fitness, weight loss, improvements in blood pressure, and 
improvements in blood cholesterol levels.  However, there is no guarantee that any or all of these 
changes will occur as a result of you participating in this study. 
 
Benefits of Reducing your Caloric and Fat Intake:  Consuming a low fat and low calorie diet 
appears to be safe and effective for weight loss.  Additional benefits of eating this type of diet can 
be improvements in blood pressure and improvements in blood cholesterol levels.  However, 
there is no guarantee that any or all of these changes will occur as a result of you participating in 
this study. 
 
If we should find out about a medical condition you were unaware of, with your written 
permission, this information will be shared with the doctor of your choice. 
  
NEW INFORMATION: 
 
You will be promptly notified if any new information develops during the conduct of this 
research study, which may cause you to change your mind about continuing to participate. 
 
COSTS and PAYMENTS: 
 
Neither you, nor your insurance provider, will be charged for the costs of any of the 
procedures performed for the purpose of this research study.  These costs will be paid by the 
sponsor of this research study.  
If you are assigned to the Weight Loss Intervention Group you will be paid $25 for 
completing the assessment following 4-weeks of the intervention, $25 for completion of the 
assessments following 12-weeks of the intervention, and $25 for completing the assessments 
following 24-weeks of the intervention.   
 If you are assigned to the Delayed Weight Loss Intervention Group you will be paid $25 
for completing assessments following the 4-week period where you are to maintain your body 
weight, $25 for completion of the assessments following 12-weeks of the intervention, and $25 
honorarium for completion of the assessments following 24-weeks of the intervention. 
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COMPENSATION FOR INJURY: 
 
University of Pittsburgh researchers and their associates who provide services at the 
University of Pittsburgh Medical Center (UPMC) recognize the importance of your voluntary 
participation in their research studies.  These individuals and their staffs will make reasonable 
efforts to minimize, control, and treat any injuries that may arise as a result of this research.  If 
you believe that you are injured as a result of the research procedures being performed, please 
contact immediately the Principal Investigator or a co-investigator listed on the first page of this 
form. 
 
Emergency medical treatment for injuries solely and directly related to your participation 
in this research study will be provided to you by UPMC.  It is possible that UPMC may bill your 
insurance provider for the costs of this emergency treatment, but none of these costs will be 
charged directly to you.  If your research-related injury requires medical care beyond this 
emergency treatment, you will be responsible for the costs of this follow-up care unless otherwise 
specifically stated below.  There is no plan for monetary compensation. You do not, however, 
waive any legal rights by signing this form.  
 
CONFIDENTIALITY: 
 
Any information about you obtained from this research will be kept as confidential 
(private) as possible.  All records related to your involvement in this research study will be stored 
in a locked file cabinet.  Your identity on these records will be indicated by a case number rather 
than by your name, and the information linking these case numbers with your identity will be 
kept separate from the research records.  In addition, all research databases will have password 
controlled access, and this will be controlled by the researchers.  Only the researchers listed on 
the first page of this form and their staff will have access to your research records.  You will not 
be identified by name in any publication of research results unless you sign a separate form 
giving your permission.   
 
This research study will involve the recording of current and/or future identifiable  
medical information from your hospital and/or other health care provider (e.g., physician office) 
records.  The information that will be recorded will be limited to information concerning medical 
clearance from your physician to participate in this research study.  This may include information 
related to coronary heart disease risk factors such as blood pressure, blood cholesterol, or other 
medical conditions that may increase the risk of heart disease and/or indicate that exercise 
participation may be unsafe for you.  This information will be used to determine whether it is safe 
for you to participate in this research study. 
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The investigators listed on the first page of this authorization (consent) form and their  
research staff will or may have access to identifiable information (which may include your 
identifiable medical record information obtained as part of the initial screening and physician 
consent) related to your participation in this research study. 
 
In unusual cases, your research records may be required to release identifiable 
information (which may include your identifiable medical record information) related to 
your participation in this research study in response to an order from a court of law.  If 
the researchers learn that you or someone with whom you are involved is in serious 
danger or potential harm, they will need to inform, as required by Pennsylvania law, the 
appropriate agencies.   
 
Authorized representatives of the University of Pittsburgh will review and/or obtain 
identifiable information (which may include your identifiable medical record 
information) related to your participation in this research study for the purpose of 
monitoring the accuracy and completeness of the research data and for performing 
required scientific analyses of the research data.  While the study sponsor understands the 
importance of maintaining the confidentiality of your identifiable research and medical 
record information, UPMC and the University of Pittsburgh cannot guarantee the 
confidentiality of this information after it has been obtained by the study sponsor. 
 
The investigators involved in the conduct of this research study may receive funding 
from the sponsor to perform the research procedures and to provide the sponsor with 
identifiable research and medical record information related to your participation in the 
study. 
 
Authorized representatives of UPMC or other affiliated health care providers may have 
access to identifiable information (which may include your identifiable medical record 
information) related to your participation in this research study for the purpose of (1) 
fulfilling orders, made by the investigators, for hospital and health care services (e.g., 
laboratory tests, diagnostic procedures) associated with research study participation; (2) 
addressing correct payment for tests and procedures ordered by the investigators; and/or 
(3) for internal hospital operations (i.e., quality assurance). 
 
 The investigators may continue to use and disclose, for the purposes described above, 
identifiable information (which may include your identifiable medical record information) related 
to your participation in this research study for 5 years following the completion of this study, as 
per University policy, or when such is approved by the sponsor of this study, whichever should 
occur last. 
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RIGHT TO PARTICIPATE or WITHDRAW FROM PARTICIPATION: 
 
Your participation in this research study, to include the use and disclosure of your 
identifiable information for the purposes described above, is completely voluntary.  (Note, 
however, that if you do not provide your consent for the use and disclosure of your identifiable 
information for the purposes described above, you will not be allowed, in general, to participate 
in the research study.)  Whether or not you provide your consent for participation in this research 
study will have no effect on your current or future relationship with the University of Pittsburgh.  
Whether or not you provide your consent for participation in this research study will have no 
effect on your current or future medical care at a UPMC hospital or affiliated health care provider 
or your current or future relationship with a health care insurance provider. 
 
You may withdraw, at any time, your consent for participation in this research study, to 
include the use and disclosure of your identifiable information for the purposes described above.  
(Note, however, that if you withdraw your consent for the use and disclosure of your identifiable 
information for the purposes described above, you will also be withdrawn, in general, from 
further participation in this research study.)  Any identifiable research or medical record 
information recorded for, or resulting from, your participation in this research study prior to the 
date that you formally withdrew your consent may continue to be used and disclosed by the 
investigators for the purposes described above. 
 
To formally withdraw your consent for participation in this research study you should 
provide a written and dated notice of this decision to the principal investigator of this research 
study at the address listed on the first page of this form. 
 
Your decision to withdraw your consent for participation in this research study will have 
no affect on your current or future relationship with the University of Pittsburgh. Your decision to 
withdraw your consent for participation in this research study will have no affect on your current 
or future medical care at a UPMC hospital or affiliated health care provider or your current or 
future relationship with a health care insurance provider. 
 
It is possible that you may be removed from the research study by the researchers if, for 
example, your health status changes and it does not appear that it is safe for you to continue to 
reduce your food intake, exercise, or lose weight. You will also be removed if you should become 
pregnant during this study. 
 
*************************************************************************** 
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VOLUNTARY CONSENT 
 
All of the above has been explained to me and all of my current questions have been 
answered.  I understand that I am encouraged to ask questions about any aspect of this research 
study during the course of this study, and that such future questions will be answered by the 
researchers listed on the first page of this form.   
 
Any questions I have about my rights as a research participant will be answered by the 
Human Subject Protection Advocate of the IRB Office, University of Pittsburgh (1-866-212-
2668). By signing this form, I agree to participate in this research study.  A copy of this consent 
form will be given to me. 
 
________________________________   __________________ 
Participant’s Signature     Date 
 
CERTIFICATION OF INFORMED CONSENT 
 
I certify that I explained the nature and purpose of this research to the above-named 
individual, and I have discussed the potential benefits and possible risks of study participation.  
Any questions the individual has about this study have been answered, and we will always be 
available to address future questions as they arise. 
 
   
Printed Name of Person Obtaining Consent  Role in Research Study 
   
   
Signature of Person Obtaining Consent  Date 
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Physical Activity Readiness Questionnaire (PAR-Q) 
 
 
Subject ID: ________________________________  Date: _____________ 
 
Please read the questions carefully and answer each one honestly: check 
YES or NO 
 
1. Has your doctor ever said you have a heart condition and that you should 
only do physical activity recommended by a doctor?  
 
     □yes □no 
 
2. Do you feel pain in your chest when you do physical activity?  
     □yes □no 
 
3. In the past month, have you had chest pain when you were not doing 
physical activity?  
     □yes □no 
 
4. Do you lose your balance because of dizziness or do you ever lose 
consciousness? 
     □yes □no 
 
5. Do you have a bone or joint problem that could be made worse by a 
change in your physical activity? 
     □yes □no 
 
6. Is your doctor currently prescribing drugs (for example, water pills) for 
your blood pressure or heart condition? 
 
     □yes □no 
 
7. Do you know of  any other reason why you should not do physical 
activity? 
     □yes □no 
 
 
Reference: American Medical Association: Guides to the Evaluation of Permanent 
Impairment.  AMA, Chicago, 1990. 
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GENERAL HEALTH HISTORY 
 
 
Subject ID:_____________________________________________________________ 
  
 
DATE: □□/□□/□□ 
 
1. Do you have or have you ever had any of the following medical conditions? 
 
       Approximate  Describe the  
       Date of  Problem 
       Diagnosis 
a. Heart Attack   □yes □no __________  ____________ 
b. Angina (chest pain on exertion) □yes □no __________  ____________ 
c. Irregular Heart Problems □yes □no __________  ____________ 
d. Other Heart Problems  □yes □no __________  ____________ 
e. Stroke    □yes □no __________  ____________ 
f. Fainting Spells   □yes □no __________  ____________ 
g. High Blood Pressure  □yes □no __________  ____________ 
h. High Cholesterol  □yes □no __________  ____________ 
i. Thyroid Problems  □yes □no __________  ____________ 
j. Cancer    □yes □no __________  ____________ 
k. Kidney Problems  □yes □no __________  ____________ 
l. Liver Problems   □yes □no __________  ____________ 
m. Gout    □yes □no __________  ____________ 
n. Diabetes    □yes □no __________  ____________ 
o. Emotional/Psychiatric Problems □yes □no __________  ____________ 
p. Drug/Alcohol Problems  □yes □no __________  ____________ 
 
2. Do you have any medical problems that would prevent you from participating in a 
regular walking program? □yes □no 
 If yes, please describe the problem:_______________________________________ 
 ___________________________________________________________________ 
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3. Have you participated in a regular exercise program over the past 6 months which 
consists of at least 20 minutes of activity, 3 days per week?  □yes □no  
 Please describe:______________________________________________________ 
 ___________________________________________________________________ 
 
4. Do you have to sleep with extra pillows or have to sit up in the middle of the night 
because of shortness of breath? □yes □no 
 
5. Please list all medications that you are currently taking on a regular basis (make sure 
to indicate if you are taking medication for high blood pressure or cholesterol): 
 MEDICATION     REASON FOR TAKING 
 _____________________________  ______________________________ 
 _____________________________  ______________________________ 
 _____________________________  ______________________________ 
 _____________________________  ______________________________ 
 
6. Over the last 6 months, on how many weekdays (Monday through Friday) do you 
usually drink wine, beer, or liquor on average? 
  (0) □  Never     (4) □ 2 days/week 
  (1) □  Less than once/month  (5) □ 3 days/week 
  (2)    □  1-2 times/month   (6) □ 4 days/week 
  (3) □  1 day/week    (7) □ 5 days/week 
 
7. On those weekdays that you drink wine, beer, or liquor how many drinks do you 
have? □□ 
 
8. Over the last 6 months, on how many weekend days (Saturday and Sunday) do you 
usually drink wine, beer, or liquor? 
  (0) □ Never     (4) □ 1 weekend day/week 
  (1) □ Less than once/month   (5) □ 2 weekend days/week 
  (2) □ 1-2 times/month     
 
9. On those weekend days that you drink wine, beer, or liquor how many drinks do 
you have? □□ 
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10. In the past year, have you regularly smoked cigarettes, pipes, cigars, or used 
chewing tobacco? 
Please describe daily habit 
 Cigarettes  □yes □no  ______________________________ 
 Pipe    □yes □no  ______________________________ 
 Cigars   □yes □no  ______________________________ 
 Chewing Tobacco □yes □no  ______________________________ 
 
11. Do you plan to spend frequent time out of town on business or vacation during the 
next 18 months? □yes □no  Please describe:_______________________ 
___________________________________________________________________ 
 
12. Is it possible that you will relocate in the next 18 months? □yes □no       Please 
describe: ______________________________________________________  
 
WOMEN ONLY ANSWER THE FOLLOWING QUESTIONS 
 
13. Are you currently pregnant? □yes □no  
 
14. Were you pregnant within the past 6 months? □yes □no 
 
15. Do you plan to become pregnant in the next 18 months? □yes □no 
 
16. Have you gone through menopause or the change of life? □yes □no 
 
17. Have you had a hysterectomy? □yes □no 
 
18. When was your last menstrual period? DATE: □□/□□/□□ 
 
19. Do you take : 
   Birth Control Pills?  □yes □no 
   Estrogens (ie. Premarin)? □yes □no 
   Progesterone (ie. Provera)? □yes □no 
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PHYSICIAN CONSENT TO PARTICIPATE IN A DIET AND EXERCISE PROGRAM 
AT THE UNIVERSITY OF PITTSBURGH 
 
TO:  RETURN TO: (envelope provided) 
 Physician’s Name John M. Jakicic, Ph.D. 
  University of Pittsburgh 
  Department of Health and Physical 
Activity 
 Address Physical Activity and Weight 
Management  
  Research Center 
  2100 Wharton Street, Suite 600 
 City State Zip Pittsburgh, PA  15203 
  Telephone: (412) 488-4184 
 (          ) FAX: (412) 488-4174 
 Telephone Number  
 
Your patient ______________________________ has asked to participate in a diet and exercise 
program at the University of Pittsburgh.  This is a 6 month research study designed to help 
patients change their eating and exercise habits and to examine the impact that this will have on 
weight loss.  This will involve the following: 
1. A walking program that will be home-based.  The exercise will gradually be progressed from 
20 minutes per day to as much as 40 minutes per day, 5 days per week.  Exercise intensity 
will be set at 60-70% of the patient’s maximal heart rate.   
 
2. A diet program that will reduce energy intake to 1200-1500 calories per day, with dietary fat 
reduced to 20-30% of total energy intake. 
 
3. Behavioral modification techniques for changing eating and exercise behaviors. 
 
4. A list of additional factors that you should consider are listed on the attached sheet.  
 
****************************************************************************** 
Please indicate below if this program seems appropriate for your patient or if you see any 
contraindications for their participation (please check the appropriate box below). 
 
 I know of no contraindications to this patient participating in any of the above components 
of the program. 
 
 I feel that this program would not be appropriate for this patient for the following reason(s): 
 
 
 
   
Signature of Physician  Date 
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Please consider the following Inclusion and Exclusion Criteria as you evaluate whether your 
patient is capable of safely participating in the weight loss research study at the University of 
Pittsburgh. 
 
Inclusion Criteria 
1. 18-55 years of age. 
2. Body mass index (BMI) between 25.0-39.9 kg/m2.  
3. Male or Female. 
Exclusion Criteria 
1. Report participating in a research project involving weight loss or physical activity in the 
previous 12 months. 
2. Report participating in any other research study that may impact the outcome of the current 
proposed study. 
3. Report a weight loss of >10% of their body weight in the previous 12 months. 
4. Report participating in regular physical activity (defined as 30 minutes per day three or more 
days per week) over the previous six months. 
5. Currently pregnant, report pregnancy during the previous 6 months, or plan on becoming 
pregnant in the following six months. 
6. Report being treated for any cardiovascular, orthopedic, psychological, neurological, or 
metabolic disorder or any other medical condition that could impact body weight, diet, or 
physical activity. 
7. Report a history of heart disease, stroke, myocardial infarction, angina, diabetes, or cancer. 
8. Report taking any medications and/or supplements that would affect heart rate or blood 
pressure responses to exercise. 
9. Report taking any medications and/or supplements that could affect metabolism and/or 
weight loss. 
10. Report an inability to attend weekly sessions or possibility of re-locating out of the greater 
Pittsburgh area during the study period. 
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Paffenbarger Physical Activity Questionnaire 
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Office Use Only 
Subject ID #:  Assessment #:  
 
EXERCISE HABITS 
1.  Was there anything about the past week that made exercising especially different for you in terms of 
extended illness, injury, or vacation?  
1Yes 2No    
 *If “NO”, please complete this questionnaire about this past week. 
*If “YES”, please complete this questionnaire about the previous week. 
2.  First, we are interested in the number of flights of stairs you climbed on average EACH DAY in this 
past week.  We only want to know the number of flights you climb going UP - not down.   
One Flight = 10 steps if you know the number of steps. 
 □□ Flights per day    
3.  Next, we want to know how many city blocks or their equivalent you walked on average EACH DAY 
in this past week.  We are only interested in walking done out of doors and walking done indoors for the 
sole purpose of exercise.  We do not want walking done around the house or at work.   
Consider that 12 city blocks = 1 mile. 
 □□ Blocks per day    
4.  Were there any sports, fitness, or recreational activities in which you participated during the past 
week?  We are interested only in time that you were physically active. 
(Note:  all walking should only be included in Question 3) 
Sport, Fitness, or Recreation Times 
per Week
 Average Time per Episode Office Use 
Only 
a. □□  □□□ Minutes □ 
b. □□  □□□ Minutes □ 
c. □□  □□□ Minutes □ 
d. □□  □□□ Minutes □ 
5.  Would you say that during the past week (the week used for questions 2-4) you were: 
 □ less active than usual    
 □ more active than usual    
 □ about as active as usual    
6.  At least once per week, do you engage in regular activity akin to brisk walking, jogging, bicycling, etc. 
long enough to work up a sweat, get your heart thumping, or get out of breath? 
 □ Yes □□ times per week; Activity:  
 □ No    
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7. On a usual weekday and a weekend day, how much time (to the nearest 1 hour) do you spend on the 
following activities?          The total for each day should add to 24 hours 
      
Sport, Fitness, or Recreation Usual Weekday 
Hours per Day 
Usual Weekend Day 
Hours per Day 
a) Vigorous Activity 
(digging in the garden, strenuous sports, 
jogging, aerobic dancing, sustained 
swimming, brisk walking, heavy carpentry, 
bicycling on hills, etc.) 
 
□□ 
 
□□ 
b) Moderate Activity 
(housework, light sports, regular walking, 
golf, yard work, lawn mowing, painting, 
repairing, light carpentry, ballroom dancing, 
bicycling on level ground, etc.) 
 
□□ 
 
□□ 
c) Light Activity  
(office work, driving car, strolling, personal 
care, standing with little motion, etc.) 
□□ □□ 
d) Sitting Activity 
(eating, reading, desk work, watching TV, 
computer work, listening to the radio, etc.) 
□□ □□ 
e) Sleeping or reclining □□ □□ 
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Appendix F 
Food Frequency Questionnaire 
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Appendix G 
Example of Lesson Topics 
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Sample Outline of Lesson Topics 
 
Session  
1 The Behavioral Approach to Changing Eating and Exercise Habits 
2 Healthy Food Choices 
3 Physical Environment – Stimulus Control 
4 Programmed Exercise 
5 Understanding and Changing Coronary Heart Disease Risk Factors 
6 Eating Patterns 
7 Lifestyle Exercise 
8 Changing the Quality of Your Diet 
9 Eating Out  in Restaurants 
10 Thoughts and Weight Control 
11 Exercising for Aerobic Fitness 
12 High-Fiber Low-Fat Eating 
13 Eating in Social Situations 
14 Problem Solving 
15 Barriers to Exercise 
16 Recipe Modification 
17 High Risk Situations 
18 Assertion and Eating 
19 Building Social Support 
20 Incorporating Strength Training into Your Exercise Program 
21 Motivation 
22 Problem Solving Revisited 
23 Getting Back on Track 
24 Looking Forward 
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Appendix H 
 
Example of Recruitment Flier 
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EXAMPLE OF RECRUITMENT FLIER 
 
Research Subjects Needed for  
Weight Loss Study 
 
Are you 18-55 years of age? 
Are you overweight and interested in losing weight? 
Do you exercise less than 3 days per week and are you interested in becoming more 
active? 
 
Women and Men who meet the above criteria and do not currently participate in a weight 
loss or exercise program may be eligible to participate in a 6-month study to examine 
strategies to achieve weight loss.  This study is being conducted at the Physical Activity 
and Weight Management Research Center at the University of Pittsburgh.  Eligible 
subjects will be compensated for their participation in this study.   
Women who are pregnant are not eligible to participate in this study. 
 
For more information please call 412-488-4172 
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Appendix I 
Recruitment Form 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 85
RECRUITMENT FORM 
 
1. Thank you for your interest in our program.  My name is __________ and I would briefly like to tell you 
about this research program. 
 
2. Procedure for Describing the Study and Obtaining Verbal Consent to Conduct the Phone 
Screen:  A description of the study will be read to participants, and this description includes important 
components of the informed consent process (see attached script).  Individuals who express an interest 
in participating in this study will be told the following to obtain verbal consent:   
Investigators Component of Informed Consent:  This study is being conducted by 
Dr. John M. Jakicic and colleagues at the University of Pittsburgh. 
Source of Support Component of Informed Consent:  This study is sponsored by 
the School of Education. 
Description Component of Informed Consent: We are interested in recruiting 50 
men and women to participate in this study.  This study will focus on examining 
strategies for weight loss and the effect of weight loss on resting energy expenditure 
and body composition.  To do this, eligible individuals will participate in a 6-month 
program that will assist you with changing your dietary habits and increasing your 
exercise.  You will receive a weight loss program that includes changes in your diet 
and exercise. You will also attend group meetings weekly for 6 months.  Please 
understand that these meetings will be held at the University of Pittsburgh in 
Southside, and meetings will start between 5:30 and 6:15 in the evening, and these 
will be held on (Day of Week to be determined). Individuals who are eligible to 
participate in this study will undergo assessments. These assessments will be 
completed before you start the study, 4 weeks after your initial assessments, and 
following at 12 and 24 weeks of participation I the weight loss program.  In addition, 
eligible individuals will complete questionnaires about their exercise and other health-
related behaviors before starting the study and following at 4, 8, 12, 16, 20 and 24 
weeks of participation.  Everyone will be paid $25 in the form of a check upon 
completion of the 4 week, 12-week and 24-week assessments which means that you 
can earn a total of $75 in incentives for your participation in this study. 
 If you are interested in participating in this study, I will need to ask you a few 
questions about your demographic background and questions about your physical 
health and medical history to determine if you appear to be eligible to participate in 
this study.  It will take approximately 5 minutes to ask you all of the questions.  If we 
complete the interview, I will ask you for some specific information (your complete 
name, date of birth, and mailing address) so that we can contact you regarding your 
participation in this study.  I will then schedule you to attend an orientation session 
that will explain all of the procedures of this study in greater detail. The average time 
to complete this Phone Screen is approximately 5 minutes.” 
Risks and Benefits Component of Informed Consent:  The only known risk to you 
for completing the Phone Screen is that it will take a few minutes of your time and you 
may experience disappointment if it is determined that you are not eligible to 
participate in the larger study.  It is likely that you will experience one or both of these 
situations by completing this Phone Screen, which means that this occurs in more 
that 25% of people (more than 25 out of 100 people).  The benefit of completing this 
Phone Screen is that you may be able to participate in the weight loss study that I 
described to you. 
Costs and Payments Component of Informed Consent:  You will not incur any 
cost nor will you receive any payment for participating in the Phone Screen.  
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Confidentiality Component of Informed Consent: If your answer to a particular 
question tells me clearly that you will not be eligible for this study, I will stop the 
interview, and not ask you any more personal questions. 
Right to Participate or Withdraw from Participation Component of Informed 
Consent: Your participation in this phone screen is voluntary.  You may refuse to 
answer any of the questions asked.   Your responses to these questions are 
confidential, and the information related to your health history or current behaviors 
that you are about to give me will be destroyed after this interview. 
 
Do you have any questions related to any of the information that I have provided to 
you? Staff member will answer any questions or will defer these questions to the 
Principal Investigator or Co-Investigator when appropriate prior to proceeding.  If the 
individual would like to think about their participation prior to proceeding with the 
Phone Screen, they will be provided with the telephone number that they can call if 
they decide to participate in the future. 
 
Voluntary Consent Component of Informed Consent:  Do you agree that the 
procedures that will be used to conduct this Phone Screen have been described to 
you, all of your questions have been answered, and you give me permission to ask 
you questions now as part of the initial Phone Screen?  If “YES” indicate the 
participant’s agreement with this statement on the top of the next page, and sign your 
name and date the form, and then complete the Phone Screen.  If “NO”, thank the 
individual for calling and do not complete the Phone Screen.  
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Page 1                                
Phone Screen Interview
 
 
 
The caller gives verbal permission to conduct the Phone Screen:   _____   YES ______  NO 
 
 
Verbal Assent was given to:___________________________________________________ 
 Signature    
 
Date  __________________________ 
 
Eligible based on telephone screening:      Yes   No  
 
 
1. Gender:   Male   Female 
2.a. Age:    (18-55)  2.b. Date of Birth:   /  /   
 
3.  Which of the following best describes your racial heritage? (you may choose more than one 
category): 
 American Indian or Alaska Native 
 Asian 
 Black or African-American 
 Hispanic, Latino, or Cape Verdean 
 Native Hawaiian or Other Pacific Islander 
 White 
 Other (Specify:__________________) 
 
4. Current Weight:     pounds      Office Use: BMI = _______(25-39.9 kg/m2) 
 
5. Current Height:  feet   inches 
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6. Are you able to walk for exercise?         YES   No 
 If “no”, specify reason: __________________________________________ 
 
7. Do you currently exercise regularly at least once per week at a moderate intensity for at 
least 20 minutes?         Yes   NO 
If “yes”, How many days per week? ________ 
 If “yes”, How long have you been exercising this way?____________ 
 
8. Have you ever been told by a doctor or other medical person that you have any of the 
following conditions?  If “yes”, Specify: 
 a. Heart Disease   Yes   NO  ________________________ 
 b. Angina    Yes   NO  ________________________ 
 c. Hypertension    Yes   NO  ________________________ 
 d. Heart Attack    Yes   NO  ________________________ 
 e. Stroke    Yes   NO  ________________________ 
 f. Diabetes (sugar)   Yes   NO  ________________________ 
 g. Cancer    Yes   NO  ________________________ 
 
9. Are you presently being treated by a doctor or other medical person for any other physical or 
psychological problems?         Yes   NO 
 If “yes”, specify: _________________________________________ 
 
10. Do you take any prescription medications (includes psychotropics)?     Yes  NO 
 If “yes”, specify the following: 
Medication Name Used to Treat: 
  
  
  
 
11. Are you taking any medications for the purpose of weight loss?    Yes   NO 
 If “yes”, specify: _________________________________________ 
 
12. Do you currently smoke?          Yes  NO 
 If “yes”, specify: _________________________________________ 
 
13. Are you currently a member of another organized exercise or are you participating in an 
organized weight reduction program?      
 θ Yes θ NO 
If “yes”, specify: _________________________________________ 
 
14. Have you lost 10 or more pounds within the past year?     Yes   NO 
If “yes”, specify number of pounds: ____Method used:_____________________ 
 
15. Are you currently participating in other research studies?     Yes   NO 
 If “yes”, specify: _________________________________________ 
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16. Have you been a participant in a previous exercise or weight control study?   Yes  NO 
 If “yes”, specify:__________________________________________ 
 
 
WOMEN ONLY COMPLETE THE FOLLOWING QUESTIONS 
17.  Are you currently pregnant?         Yes     NO 
A. Have you been pregnant in the last 6 months?      Yes   NO 
B. Do you plan on becoming pregnant in the next 6 months?    Yes   NO 
 If “yes”, specify: _______________________________________ 
 
18. Do you plan to spend any time out of town on vacation or business in the next 6 months 
that may affect your ability to attend weekly group meetings?    
           Yes   NO 
 If “yes”, specify: _________________________________________ 
 
18.  Do you plan on relocating outside of the Greater Pittsburgh Area within the next 6 months?  
  Yes   NO 
 If “yes”, specify: _________________________________________ 
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Contact Tracking Form (Stepped Care Study) 
 
 
** THIS PAGE IS COMPLETED ONLY IF THE RESPONDANT APPEARS TO QUALIFY FOR 
PARTICIPATION IN THIS STUDY AND IS SCHEDULE FOR THE ORIENTATION VISIT. ** 
 
Date: ____/____/____  Staff Member Completing Form: 
___________________ 
 
Name: _______________________________________________________ 
 
Street Address: ________________________________________________ 
 
City: _____________________________   State: ___  Zip Code:________ 
 
Home Phone: ___________________ Work Phone: ___________________ 
 
OFFICE USE ONLY: Eligible:      yes  No  
  Invited to Orientation:   yes  No Date:____/____/____ 
 
 
 
If eligible schedule the participant for their group orientation session based 
on the schedule of available dates.  A follow-up reminder will be send via the 
mail. 
 
 
 
 
PAGE 1 WILL BE RETAINED FOR DEMOGRAPHIC STATISTICS 
 
 
PAGES 2-3 MUST BE SHREDDED AT THE CONCLUSION OF THIS 
INTERVIEW 
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